YEM Search

Plant Summary

Plant Information

TCMBank_ID:	TCMBANKHE004506 TCMBANKHE004505 TCMBANKHE006552 TCMBANKHE000220
YEM_ID:	YEM-137
ID:	TCMBANKHE004506/YEM-137 TCMBANKHE004505/YEM-137 TCMBANKHE006552/YEM-137 TCMBANKHE000220/YEM-137
植物拉丁名:	Radix Notoginseng\|Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al. Panax pseudo-ginseng var. notoginseng [Syn. Panax notoginseng ]\|Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al. Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al.
功能与主治:	To eliminate blood stasis, arrest bleeding, cause subsidence of swelling and alleviate pain./Hemoptysis, blood ejection, spontaneous external bleeding, hematochezia, flooding and spotting, bleeding due to external injury, angina pectoris, stabbing pain in chest and abdomen, painful swelling from knocks and falls. Treatment of hemoptysis, hematemesis, epistaxis, hematochezia, abnormal uterine bleeding, traumatic bleeding, pricking pain in the chest and abdomen, traumatic swelling and pain./1. Flavonoid glycoside, one of its components, increases coronary flow, reduces myocardial oxygen consumption and lowers arterial pressure.2.Cardiotonic on frogs' hearts in vitro; low concentration of its extract exerts a vasoconstrictive effect on the vessels of frogs' leg and high concentration, vasodilative3. Its liquid extract shortens clotting time and exerts hemostatic effect in rabbit. To clear heat and engender liquid, calm liver and lower blood pressure./Fluid damage and thirst, aphonia due to throat pain, hypertension.
药用植物名:	三七汉三七\|三七三七花蕾\|三七三七叶\|三七
药名:	三七
来源:	云南民族药物志：第一卷
药用部位:	root Panax notoginseng (Burk. ) F. H. Chen. flower
使用民族:	彝族
药味:	Warm; Pungent; Slightly Bitter
经络:	Stomach; Liver
临床特征:	1. Flavonoid glycoside, one of its components, increases coronary flow, reduces myocardial oxygen consumption and lowers arterial pressure.2.Cardiotonic on frogs' hearts in vitro; low concentration of its extract exerts a vasoconstrictive effect on the ve
治疗类型:	化瘀止血药止血
TCM_ID_id:	2443 1452 8120 3617
SymMap_id:	346
TCMSP_id:	602 317

植物对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN000006	evodiamine	l-Evodiamine; BDBM50366821; BB_NC-1930; ZINC00898159; Evodiamine, <i>Evodia rutaecarpa; evodiamine ; 518-17-2; CHEMBL486598; Evodiamine; ZINC2031813; C09187	C19H17N3O	303.36	CN1C2C3=C(CCN2C(=O)C4=CC=CC=C41)C5=CC=CC=C5N3
TCMBANKIN000098	linamarin	CHEBI:16441; 2-(beta-D-Glucopyranosyloxy)-2-methylpropionitrile; SR-05000002494-1; CTK8G0586; BSPBio_003283; KBioSS_002500; BICL4127; SCHEMBL42021; FT-0608720; KBio2_007628; 1-cyano-1-methylethyl beta-D-glucoside; KBio3_002503; C01594; Spectrum_001946; SpecPlus_000936; Spectrum3_001622; CCG-39428; 2-beta-d-glucopyranosyloxy-2-methylpropanenitrile; CHEMBL3039425; 2-(; LINAMARIN; SPBio_002123; KBio1_001976; W-203090; alpha-Hydroxyisobutyronitrile beta-D-glucopyranoside, >=98.0% (HPLC); Propanenitrile, 2-(beta-D-glucopyranosyloxy)-2-methyl-; NCGC00178164-01; 2-Methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)propanenitrile; 5-17-07-00397 (Beilstein Handbook Reference); AKOS030242445; MFCD00036209; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-propanenitrile; alpha-Hydroxyisobutyronitrile beta-D-glucopyranoside; Linamarin; LS-120874; Spectrum5_000575; DTXSID8052857; Manihotoxin; KBio2_005060; SR-05000002494; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-propionitrile; KBio2_002492; H3V9RP3WLO; UNII-H3V9RP3WLO; BRN 0019237; 2-(beta-D-Glucopyranosyloxy)-2-methyl-Propanenitrile; DivK1c_007032; 2-(beta-D-Glucopyranosyloxy)-2-methylpropanenitrile; HSDB 3507; alpha-Hydroxyisobutyronitrile-beta-D-glucose; 2-(beta-D-Glucopyranosyloxy)isobutyronitrile; A-D-Glucopyranosyloxy)-2-methyl-propanenitrile; Spectrum2_001972; alpha-Hydroxyisobutyronitrile beta-D-glucose; 2-methyl-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]propanenitrile; C-51988; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-propanenitrile; MolPort-003-665-717; A-D-Glucopyranosyloxy)-2-methylpropionitrile; ZINC3984017; Phaseolunatin; KBioGR_002195; 2-(b-D-Glucopyranosyloxy)-2-methylpropanenitrile, 9CI; SPECTRUM1504124; SDCCGMLS-0066829.P001; 2-methyl-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanenitrile; Spectrum4_001668; AC1L1WOH; 554-35-8; AK600739; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanenitrile	C10H17NO6	247.24 g/mol	CC(C)(C#N)OC1C(C(C(C(O1)CO)O)O)O
TCMBANKIN000100	lauric acid	NCGC00090919-01; CHEBI:30805; n-Dodecanoic acid; Hydrofol acid 1255; Wecoline 1295; Neo-Fat 12-43; 8045-27-0; WLN: QV11; AI3-00112; AIDS-049202; 61609_FLUKA; Dodecylcarboxylate; DAO; EINECS 205-582-1; L-ALFA-LYSOPHOSPHATIDYLCHOLINE, LAUROYL; CCRIS 669; W261408_ALDRICH; lauric acid ; 8000-62-2; DODECANOIC ACID (LAURIC ACID); C-1297; 7632-48-6; ST023796; NSC5026; Laurinsaeure; C02679; [2-((1-OXODODECANOXY-(2-HYDROXY-3-PROPANYL))-PHOSPHONATE-OXY)-ETHYL]-TRIMETHYLAMMONIUM; Dodecoic acid; Laurostearic acid; NCGC00090919-02; 4-02-00-01082 (Beilstein Handbook Reference); lauricacid; Ninol AA62 extra; InChI=1/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14; Lauric acid (natural); Aliphat No. 4; NSC-5026; Coconut oil fatty acids; Lauric acid, pure; 203714-07-2; NCIOpen2_009480; CH3-[CH2]10-COOH; Dodecylic acid; Neo-Fat 12; AIDS049202; C12 fatty acid; HSDB 6814; Dodecanoic acid; L556_ALDRICH; Lauric acid; LAP; Univol U-314; FEMA No. 2614; 1-Undecanecarboxylic acid; Vulvic acid; 143-07-7; BRN 1099477; Duodecylic acid; LAU; W261416_ALDRICH; LMFA01010012; L4250_SIGMA; Hydrofol acid 1295	C12H24O2	200.32	CCCCCCCCCCCC(=O)O
TCMBANKIN000145	10Z,13Z-nonadecadienoic acid	cis-10, cis-13-nonadecadienoic acid; LMFA01030129; (10Z,13Z)-nonadeca-10,13-dienoic acid	C19H34O2	294.5 g/mol	CCCCCC=CCC=CCCCCCCCCC(=O)O
TCMBANKIN000984	(9Z,12E)-octadeca-9,12-dienoic acid methyl ester	EINECS 243-607-8; 20221-27-6; Methyl (9Z,12E)-octadeca-9,12-dienoate	C19H34O2	294.47	CCCCCC=CCC=CCCCCCCCC(=O)OC
TCMBANKIN001709	(1R,2S)-1-ethyl-2-methylcyclopropane	(1R,2S)-1-ethyl-2-methyl-cyclopropane		84.18
TCMBANKIN001734	14-methylhexadecanoicacid	14-methyl hexadecanoic acid	C17H34O2	270.5 g/mol	CCC(C)CCCCCCCCCCCCC(=O)O
TCMBANKIN001911	Encecalin	CHEMBL451983; CHEBI:4789; NSC603929; C09005; 1-(7-Methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)ethanone; Ketone, 7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl methyl; 20628-09-5; encecalin; 4CN-1599; SCHEMBL4310132; WXVLCNREBFDEKS-UHFFFAOYSA-N; AKOS032948499; NSC-603929; 1-(7-methoxy-2,2-dimethyl-2h-chromen-6-yl)ethanone; ZINC897924; Isolated from Asteraceae plants; Encecaline; NSC 603929; 1-(7-methoxy-2,2-dimethyl-chromen-6-yl)ethanone; ACon1_002222; 1-(7-methoxy-2,2-dimethylchromen-6-yl)ethanone; Encecalin (methyleupatoriochromene); Ethanone,1-(7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-; W1949; AC1Q5GA2; 6-acetyl-7-methoxy-2,2-dimethylchromene; 1-(7-methoxy-2,2-dimethyl-6-chromenyl)ethanone; MolPort-001-742-371; AC1L3FTK; CTK8D7503; MEGxp0_001567; NP-009521; MCULE-1012949526	C14H16O3	232.27	CC(=O)C1=C(C=C2C(=C1)C=CC(O2)(C)C)OC
TCMBANKIN001976	ZINC01532096	(1S,5R)-3-(3,5-dichlorophenyl)-1,5-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-quinone; ZINC01532095; (1S,5R)-3-(3,5-dichlorophenyl)-1,5-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione		284.15
TCMBANKIN002350	20(s)-ginsenosiderh2	20(s)-ginsenoside-rh2	C36H62O8	622.9 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C
TCMBANKIN002812	notoginsenosider2	notoginsenoside R2; notoginsenoside r2	C41H70O13	771 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(CO6)O)O)O)C)O)C)O)C
TCMBANKIN002919	Butylcyclobutane	Cyclobutane, butyl-	C8H16	112.21 g/mol	CCCCC1CCC1
TCMBANKIN002965	Ethyl-p-digallate	ethyl-p-digallate; ethyl 3,5-dihydroxy-4-(3,4,5-trihydroxyphenyl)carbonyloxy-benzoate; AC1NSVBL; 3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyl)oxy-benzoic acid ethyl ester; (4-ethoxycarbonyl-2,6-dihydroxyphenyl) 3,4,5-trihydroxybenzoate; ethyl 3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyl)oxybenzoate; ethyl 3,5-dihydroxy-4-(3,4,5-trihydroxybenzoyl)oxy-benzoate; 3,5-dihydroxy-4-[oxo-(3,4,5-trihydroxyphenyl)methoxy]benzoic acid ethyl ester		350.3	CCOC(=O)C1=CC(=C(C(=C1)O)OC(=O)C2=CC(=C(C(=C2)O)O)O)O
TCMBANKIN003186	(4aS,9aR)-2,9,9-trimethyl-5-methylene-4,4a,6,7,8,9a-hexahydro-3H-benzo[7]annulene	(4aS,9aR)-2,9,9-trimethyl-5-methylidene-4,4a,6,7,8,9a-hexahydro-3H-benzo[7]annulene	C15H24	204.35
TCMBANKIN003657	WLN: QR DG	AI3-19422; NINDS_000310; Spectrum3_000539; 25865_FLUKA; IDI1_000310; KBio2_001419; KBioSS_001419; 35826_RIEDEL; Phenol, 4-chloro-; 106-48-9; 4-Chlorophenol; NSC 2877; NCGC00090814-01; Parachlorophenol (JAN/USP); Spectrum4_000468; DivK1c_000310; KBio3_001657; p-Chlorophenol; 185787_ALDRICH; D00149; KBio1_000310; AIDS017748; c0295; NSC2877; 4-Monochlorophenol; Spectrum_000939; p-Chlorophenol, solid [UN2020] [Keep away from food]; 4-Hydroxychlorobenzene; 4-Chlorophenol solution; C02124; NCGC00090814-02; Parachlorophenol; HSDB 1414; p-Chlorfenol; p-Chlorophenol, liquid [UN2021] [Keep away from food]; AIDS-017748; CHEBI:28078; EINECS 203-402-6; KBioGR_000916; KBio2_003987; p-Chlorophenic acid; 442411_SUPELCO; Applied 3-78; NCGC00090814-03; Spectrum2_000968; 4-Chloro-1-hydroxybenzene; BSPBio_002157; ZINC00001885; Spectrum5_001228; SPECTRUM1500460; SPBio_000975; ST5214454; CCRIS 642; Phenol, p-chloro-; InChI=1/C6H5ClO/c7-5-1-3-6(8)4-2-5/h1-4,8; KBio2_006555	C6H5ClO	128.56	C1=CC(=CC=C1O)Cl
TCMBANKIN003665	evoden				C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
TCMBANKIN004218	(1S,4S)-7-isopropylidene-1,4-dimethyl-2,3,4,5,6,8-hexahydro-1H-azulene	(1S,4S)-1,4-dimethyl-7-propan-2-ylidene-2,3,4,5,6,8-hexahydro-1H-azulene	C15H24	204.35
TCMBANKIN004744	6β-acetoxy-epilimonin
TCMBANKIN004861	cyclododecanone	I14-19848; F0001-2129; LS-191395; Z1258578308; MCULE-8431279332; InChI=1/C12H22O/c13-12-10-8-6-4-2-1-3-5-7-9-11-12/h1-11H; MolPort-000-727-778; Cyclododecanone, >=99%; NSC 77116; CTK3E8944; AK609278; NSC77116; AS-10382; KS-00000WK2; CJ-10851; NCGC00163980-02; AKOS000118913; Tox21_201557; BB_NC-0279; DB-056676; DSSTox_GSID_27322; NCGC00163980-01; EC 212-595-6; UNII-WL053118A9; SXVPOSFURRDKBO-UHFFFAOYSA-N; DSSTox_CID_7322; WL053118A9; ANW-37643; TR-037928; NCGC00259106-01; ZINC3860296; RTR-037928; ACMC-209pr1; BBL019121; NCGC00256984-01; STK301634; T8208; ST45061384; CDON; cyclododecan-1-one; W-109097; SCHEMBL190509; CAS-830-13-7; CYCLODODECANONE; HSDB 5762; 830-13-7; NSC-77116; DTXSID3027322; FT-0624164; DSSTox_RID_78407; AC1L21CI; MFCD00003722; cyclododecanon; EINECS 212-595-6; KSC448S4J; Tox21_303048; CHEMBL1883853; SBB060076; TRA0043398; 6022AF	C12H22O	182.3 g/mol	C1CCCCCC(=O)CCCCC1
TCMBANKIN004971	dicapryl phthalate	SCHEMBL167309; Jsp001875	C24H42O4	394.6 g/mol	CCCCCCCC.CCCCCCCC.C1=CC=C(C(=C1)C(=O)O)C(=O)O
TCMBANKIN005294	ginsenoside rd_qt	ginsenoside- F3_qt; ginsenoside F2_qt; notoginsenosider4_qt	C42H72O13	785.01
TCMBANKIN008084	Daturic acid	67701-03-5; daturicacid; n-Heptadecylic acid; EINECS 266-928-5; 51610_FLUKA; 67255-22-5; 68424-37-3; NSC3743; (C16-C18)Alkylcarboxylic acid; WLN: QV16; NSC 3743; SDA 19-005-00; 8043-36-5; CH3-[CH2]15-COOH; EINECS 264-123-3; 506-12-7; LMFA01010017; AI3-36481; EINECS 208-027-1; Lead(2+) heptadecanoate; 37231-04-2; Margaric acid; 45237-52-3; n-Heptadecanoic acid; 7722-21-6; 63399-94-0; Heptadecylic acid; n-Heptadecoic acid; 39390-60-8; heptadecoic acid; 8000-11-1; (C16-C18) Alkylcarboxylic acid; daturic acid; C14-C22 Fatty acid residue; Heptadecanoic acid; Margarinsaeure; 8034-57-9; CHEBI:32365; Fatty acids, C14-22; 28829-31-4; 8034-58-0; 1338-46-1; 52051-63-5; EINECS 270-298-7; 8034-56-8; 4-02-00-01193 (Beilstein Handbook Reference); Fatty acids, C16-18; BRN 1781004; 176435-16-8; 45237-51-2; H3500_SIGMA; Margarinic acid	C17H34O2Pb	478 g/mol	CCCCCCCCCCCCCCCCC(=O)O.[Pb]
TCMBANKIN008689	α-cyperene			204.39
TCMBANKIN008989	notoginsenosider3_qt			460.82
TCMBANKIN010282	MEHQ	1-Hydroxy-4-methoxybenzene; p-Guaiacol; Novo-Dermoquinona; EINECS 205-769-8; WLN: QR DO1; Mequinol [DCF:INN]; p-Methoxyphenol; Leucobasal; 4-Hydroxyphenol, polymer-bound; Hydroquinone monomethyl ether; PHENOL,4-METHOXY; Phenol, 4-methoxy-; Mono methyl ether hydroquinone; 4-Methoxyphenol; Mequinol (USAN); InChI=1/C7H8O2/c1-9-7-4-2-6(8)3-5-7/h2-5,8H,1H; M18655_ALDRICH; HQMME; Mequinol; CCRIS 5531; Mequinolum [INN-Latin]; Monomethyl ether hydroquinone; Mechinolo [DCIT]; 54050_FLUKA; 650382_ALDRICH; HSDB 4258; 4-Hydroxyanisole; NSC 4960; Mechinolum; p-Hydroxyanisole; Leucodine B; AI3-00841; NCGC00091390-01; PMF (antioxidant); p-Hydroxymethoxybenzene; Usaf an-7; 150-76-5; SB 01123; BMS 181158; ZINC00001684; NSC4960; NCI60_004190; D04926; Hydroquinone methyl ether; Phenol, p-methoxy-; NCIMech_000709	C7H8O2	124.14	COC1=CC=C(C=C1)O
TCMBANKIN010290	coprine	2-amino-5-[(1-hydroxycyclopropyl)amino]-5-oxopentanoic acid; AC1NAMAQ; 2-amino-4-[(1-hydroxycyclopropyl)carbamoyl]butanoic acid; L-coprine	C8H14N2O4	202.21 g/mol	C1CC1(NC(=O)CCC(C(=O)O)N)O
TCMBANKIN011010	1-methyl-5-isopropenyl cyclohexene	1-methyl-5-(1-methylethenyl)-cyclohexene	C10H16	136.23	CC1=CCCC(C1)C(=C)C
TCMBANKIN012145	2-tridecyl-4-(1h)-quinolone	2-tridecyl-4(1h)-quinolone	C22H33NO	327.5 g/mol	CCCCCCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1
TCMBANKIN012209	(1S,4S,4aS,6S,8aS)-4-isopropyl-1,6-dimethyldecahydronaphthalene	(1S,4S,4aS,6S,8aS)-1,6-dimethyl-4-(propan-2-yl)decahydronaphthalene; CHEBI:36513; (1S,4S,4aS,6S,8aS)-4-isopropyl-1,6-dimethyl-decalin; (1S,4S,4aS,6S,8aS)-1,6-dimethyl-4-propan-2-yl-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalene; (1S,4S,4aS,6S,8aS)-4-isopropyl-1,6-dimethyldecalin	C15H28	208.38 g/mol	CC1CCC2C(CCC(C2C1)C(C)C)C
TCMBANKIN012328	3,4-Dichlorobutane nitrile		C4H5Cl2N	137.99 g/mol	C(C#N)C(CCl)Cl
TCMBANKIN012769	3-o-[β-d-glucopyranosyl(1→6)-β-d-glucopy-ranosyl]-20-o-β-d-glucopyranosyl-3β,12β,20(s)-trihydroxydammar-24-ene		C48H82O18
TCMBANKIN012798	1-methyl-2-[(z)-6-pentadecenyl]-4(1h)-quinolone	AC1O3DPC; 1-methyl-2-pentadec-6-enylquinolin-4-one; 1-methyl-2-pentadec-6-enyl-4( 1h)-quinolone	C25H37NO	367.6 g/mol	CCCCCCCCC=CCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN012990	hydroxyevodiamine	hydroxy evodiamine; Ambotz526-43-2; 13b-Hydroxy-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one; MolPort-020-005-715; hydroxyevodiamine	C19H17N3O2	319.36
TCMBANKIN014524	gossypetin	C-19555; CC-29066; 2-[3,4-bis(oxidanyl)phenyl]-3,5,7,8-tetrakis(oxidanyl)chromen-4-one; LMPK12113231; 3,3',4',5,7,8-Hexahydroxyflavone; SCHEMBL157033; BSPBio_002552; 2-(3,4-Dihydroxyphenyl)-3,5,7,8-tetrahydroxychromen-4-one; YRRAGUMVDQQZIY-UHFFFAOYSA-N; Articulatidin; 2-(3,4-Dihydroxyphenyl)-3,5,7,8-tetrahydroxy-4H-chromen-4-one; NCGC00178604-01; SR-05000002577-1; ST059622; CHEBI:16400; Gossypetin; MCULE-3233813708; BDBM26655; 489-35-0; SR-05000002577; VA11031; SET4M23ZTM; FT-0632211; C04109; BRD-K06692906-001-01-6; 2-(3,4-dihydroxyphenyl)-3,5,7,8-tetrahydroxy-4-chromenone; 2-(3,4-dihydroxyphenyl)-3,5,7,8-tetrahydroxy-chromone; 2-(3,4-dihydroxyphenyl)-3,5,7,8-tetrahydroxy-4H-chromen-4-one; 3,5,7,8,3',4'-Hexahydroxyflavone; BP-10444; 4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3,5,7,8-tetrahydroxy-; CHEMBL253570; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7,8-tetrahydroxy-; SPECTRUM1505143; PubChem9855; A827629; 9464AF; 2-(3,4-dihydroxyphenyl)-3,5,7,8-tetrahydroxy-1-benzopyran-4-one; DTXSID50197631; ZINC6525297; UNII-SET4M23ZTM; AKOS024283047; NCGC00096031-02; AC1NQXCW; NCGC00096031-01; MFCD00017680; CCG-231029; 2-(3,4-Dihydroxyphenyl)-3,5,7,8-tetrahydroxy-4H-chromen-4-one #; 2-(3,4-dihydroxyphenyl)-3,5,7,8-tetrahydroxy-chromen-4-one; 2-(3,4-Dihydroxy-phenyl)-3,5,7,8-tetrahydroxy-chromen-4-one; D0Z7EL; Equisporol	C15H10O8	318.24	C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C(=C(C=C3O)O)O)O)O)O
TCMBANKIN014832	rutamine	rutamine
TCMBANKIN015100	flavonoid glycoside
TCMBANKIN015785	evgin
TCMBANKIN017713	Obamegine	C06513; 57377-42-1; AIDS-171573; AIDS171573; ZINC40163548; 15,30-Diaza-20,25-dimethoxy-15,30-dimethyl-7,23-dioxaheptacyclo[22.6.2.2<3,6>.1<8,12>.1<14,18>.0<22,36>.0<27,31>]hexatriaconta-3(33),4,6(34),8,10,12(35),18(36),19,21,24,26,31-dodecaene-9,21-diol; (1'.BETA.)-6,6'-DIMETHOXY-2,2'-DIMETHYLBERBAMAN-7,12-DIOL; obamegine; Krukovine	C36H38N2O6	594.7	CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)O)O)OC
TCMBANKIN017785	protopanoxadiol		C30H52O3	460.73
TCMBANKIN018324	(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol	(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol	C42H72O14	801.01
TCMBANKIN018519	2,8-dimethyl-undecanoic
TCMBANKIN018651	Tetrahydromagnolol	tetrahydro-magnolol; 2-(2-hydroxy-5-propyl-phenyl)-4-propyl-phenol; DTXSID30415784; CHEMBL32362; magnolignan; D09209; AK558283; MolPort-044-561-199; CTK0J8666; 5,5'-Dipropyl-[1,1'-biphenyl]-2,2'-diol; SCHEMBL662610; 2,2'-dihydroxy-5,5'-dipropyl-biphenyl; 20601-85-8; [1,1'-Biphenyl]-2,2'-diol, 5,5'-dipropyl-; MLO; tetrahydromagnolol; AKOS030533113; 2-(2-hydroxy-5-propylphenyl)-4-propylphenol; BDBM50428092; ZINC29227697; AC1NT0WA	C18H22O2	270.4 g/mol	CCCC1=CC(=C(C=C1)O)C2=C(C=CC(=C2)CCC)O
TCMBANKIN018853	Octadecyne	SBB009112; EINECS 211-114-7; 629-89-0; octadec-1-yne; 1-Octadecyne	C18H34	250.46	CCCCCCCCCCCCCCCCC#C
TCMBANKIN018974	erocarpine
TCMBANKIN019026	9,10-dihydroxystearicacid	D8539_SIGMA; (9R,10R)-Dihydroxyoctadecanoic acid; UNII-SQL1V605V5; Threo-9,10-dihydroxyoctadecanoic acid; ZINC30726317; 9,10-dihydroxystearic acid; C08314; threo-9,10-Dihydroxystearic acid; UNII-6C8DC6UQ5A component VACHUYIREGFMSP-IAGOWNOFSA-N; UNII-SQL1V605V5 component VACHUYIREGFMSP-IAGOWNOFSA-N; (9R,10R)-9,10-Dihydroxyoctadecanoic acid; LMFA01050527; Octadecanoic acid, 9,10-dihydroxy-, threo-; FT-0667157; Octadecanoic acid, 9,10-dihydroxy-, (9R,10R)-rel-; Octadecanoic acid, 9,10-dihydroxy-, (R,R)-; 9,10-Dihydroxystearic acid, threo-	C18H36O4	316.5 g/mol	CCCCCCCCC(C(CCCCCCCC(=O)O)O)O
TCMBANKIN019381	Pancratistatin	C08535; 96203-70-2; NCI60_003105; pancratistatin; SMP1_000217; NSC349156; NCIMech_000573; AC1O8OET; (1R,2S,3R,4R,4aS,11bR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one	C14H15NO8	325.27	C1OC2=C(O1)C(=C3C(=C2)C4C(C(C(C(C4O)O)O)O)NC3=O)O
TCMBANKIN019480	[(1R)-1-methoxyethyl]benzene			136.21
TCMBANKIN019650	isoevodiamine	Evodiamine, (+)-; 21-METHYL-3,13,21-TRIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4(9),5,7,15,17,19-HEPTAEN-14-ONE; SR-05000002159-2; MFCD06407824; E1012; 518-18-3; AS-15078; SR-05000002159; AC-24421; NCGC00163553-02; MolPort-003-983-878; ST51052658; AN-45498; N923; CCG-208627; d-Evodiamine; Evodiamine (Isoevodiamine); CHEMBL81925; SureCN682158; MCULE-3374039628; API0002668; 8,13,13b,14-Tetrahydro-14-methylindolo[2'3'-3,4]pyrido[2,1-b]quinazolin-5-[7H]-one; 21-methyl-3,13,21-triazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8,15(20),16,18-heptaen-14-one; CHEBI:95196; AKOS015894237; BRD-A68631409-001-01-3; (??)-Evodiamine; evodiamine, (S)-isomer; 21-methyl-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20] henicosa-2(10),4,6,8,15,17,19-heptaen-14-one; Oprea1_236793; BCP9000671; Isoevodiamine; Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (S)-; BDBM50016250; LS-175304; PubChem18244; BC216230; Evodiamine;; SCHEMBL139349; NSC-258314; 5956-87-6; 14-METHYL-5-OXO-7,8-DIHYDRO-5H-INDOLO[2,3:3,4]PYRIDO[2,1-B]QUINAZOLIN-14-IUM-13-IDE; I05-0067; Indolo(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-; (+/-)-Evodiamine; Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)-; s2382; AC1L461L; NSC258314; NCGC00163553-01; 8,13,13b,14-tetrahydro-14-methylindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7h)-one; AC1L9C8E; C19H17N3O	C19H17N3O	303.4 g/mol	CN1C2C3=C(CCN2C(=O)C4=CC=CC=C41)C5=CC=CC=C5N3
TCMBANKIN019670	carboxy evodiamine	carboxyevodiamine	C20H17N3O3	347.4 g/mol	CN1C2C3=C(CC(N2C(=O)C4=CC=CC=C41)C(=O)O)C5=CC=CC=C5N3
TCMBANKIN019900	5- alkene-3β- stigmasterol
TCMBANKIN020195	(+)-Ledol	577-27-5; C09698; 1H-Cycloprop(e)azulen-4-ol, decahydro-1,1,4,7-tetramethyl-, (1aR-(1aalpha,4alpha,4abeta,7alpha,7abeta,7balpha))-	C15H26O	222.37 g/mol	CC1CCC2C1C3C(C3(C)C)CCC2(C)O
TCMBANKIN020564	2,6-di-tert-butyl-4-methy-phenol
TCMBANKIN020751	(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol	(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol	C53H90O22	1079.27
TCMBANKIN021434	DL-Glucuronic acid	87246-82-0; 87090-89-9; (2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid; C16245; 36116-79-7; 6556-12-3; (2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxo-hexanoic acid; EINECS 229-486-4; (2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-keto-hexanoic acid; 12758-41-7; EINECS 209-401-7	C6H10O7	194.14	C(=O)C(C(C(C(C(=O)O)O)O)O)O
TCMBANKIN021909	Evodiamide	N-[2-(1H-indol-3-yl)ethyl]-N-methyl-2-methylaminobenzamide; AC1Q5FLA; A813575; Benzamide, N-(2-(1H-indol-3-yl)ethyl)-N-methyl-2-(methylamino)-; N-[2-(1H-indol-3-yl)ethyl]-N-methyl-2-methylamino-benzamide; 116965-70-9; evodiamide; n-[2-(1h-indol-3-yl)ethyl]-n-methyl-2-(methylamino)benzamide; AC1L4OQR	C19H21N3O	307.39	CNC1=CC=CC=C1C(=O)N(C)CCC2=CNC3=CC=CC=C32
TCMBANKIN022927	Evocarpine	1-methyl-2-[(Z)-tridec-8-enyl]-4-quinolone; 11036-30-9; 1-METHYL-8-[(2E)-TRIDEC-2-EN-1-YL]QUINOLIN-4-ONE; 1-methyl-2-[(Z)-tridec-8-enyl]quinolin-4-one; AC1O6A4R; 1-methyl-2-[(Z)-tridec-8-enyl]-4-quinolinone; 1-methyl-8-[(E)-tridec-2-enyl]quinolin-4-one; evocarpine; SCHEMBL15942080	C23H33NO	339.51	CCCCC=CCCCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN022980	caprylic acid	Octanoic acid (mixed isomers); AK405365; octoic acid; Sodium octanoate, 96%; Natrium octanoat; D05220; NoO notEa AAENI; W279927_ALDRICH; Sodium caprylate [NF]; KB-80641; ACMC-1BO0W; MCULE-8227046407; AIDS-006110; Caprylsaeure; V0353; Octylic acid; Enantic acid; Caprylic acid sodium salt; Sodium n-octanoate; Sodium octoate; Octanoic acid sodium salt; 68937-74-6; MolPort-006-113-836; EINECS 273-085-7; C-8 acid; 21639_FLUKA; HSDB 5862; AIDS006110; NCGC00090957-02; 0ctanoic acid; BYKRNSHANADUFY-UHFFFAOYSA-M; Acid C-8; caprylic acid, sodium salt; 124-07-2; Acido octanoico [Spanish]; Sodium octanoate, 96% 100g; Octic acid; 124-07-2 (Parent); W279900_ALDRICH; KS-00000YJH; capryloate; Sodium caprylate: Octanoic acid; NCGC00090957-01; Acide octanoique [French]; Sodium caprylate (NF); O0034; UNII-9XTM81VK2B; LS-98001; 18312-04-4; neo-fat 8; OCTANOIC ACID (CAPRYLIC ACID); SODIUM OCTANOATE; 1-heptanecarboxylic acid; NCIOpen2_009358; LS-691; O3907_ALDRICH; 1984/6/1; CHEBI:132100; MFCD00058511; AN-19785; ANW-13619; NCIOpen2_002902; octanoic acid; C2875_SIGMA; I14-14709; TR-009215; Caprylic acid (natural); NSC 5024; CHEBI:28837; Octanoic acid [USAN:INN]; LMFA01010008; n-octylic acid; TRA-0206488; Fatty acids, C6-1O; FEMA No. 2799; BRN 1747180; 4-02-00-00982 (Beilstein Handbook Reference); 9XTM81VK2B; EINECS 204-677-5; CHEMBL557076; Octanoic acid, sodium salt; EINECS 217-850-5; ST51037190; KSC490S9T; caprylic acid ; NSC5024; AI3-50473; SCHEMBL56211; Sodium Salt of Caprylic Acid; Octanoic acid (USAN); Hexacid 898; CH3-[CH2]6-COOH; Sodium caprylate; Sodium caprylate [USAN]; RTR-009215; 27633_RIEDEL; Kaprylsaeure; C06423; Fatty acids, C6-10; caprylicacid; Acidum octanocium [Latin]; HSDB 821; AI3-04162; Kyselina kaprylova [Czech]; n-octanoic acid; FT-0701289; n-caprylic acid; AS-17478; CCRIS 4689; PubChem12870; 21650_FLUKA; n-Octoic acid; W-109735; CTK3J0999; AKOS015901906; OCA; Octansaeure; SC-79959; n-Octanoic Acid Sodium Salt; WLN: QV7; CPD-195; Octanoic acid, sodium salt (1:1); DTXSID3027451; D08999	C8H16O2	144.21 g/mol	CCCCCCCC(=O)O
TCMBANKIN023506	3,4-DIMETHYLBIPHENYL	4433-11-8; 1,2-dimethyl-4-phenyl-benzene; 1,1'-Biphenyl, 3,4-dimethyl-; 1,2-dimethyl-4-phenylbenzene	C14H14	182.26 g/mol	CC1=C(C=C(C=C1)C2=CC=CC=C2)C
TCMBANKIN023797	2-octanone	Methyl hexyl ketone; 4-01-00-03339 (Beilstein Handbook Reference); FEMA No. 2802; n-Hexyl methyl ketone; O4709_SIAL; Octanone; NSC 3712; NSC5936; 2-Octanone; EINECS 203-837-1; 27457-18-7; 2-Oxooctane; AI3-05617; HSDB 5545; FEMA Number 2802; Octan-2-one; 2-Octanone (natural); Methyl n-hexyl ketone; 111-13-7; ZINC01672808; BRN 0635843; 2- Octanone; 02479_FLUKA; Hexyl methyl ketone; NSC3712; W280208_ALDRICH	C8H16O	128.21	CCCCCCC(=O)C
TCMBANKIN024175	(2S,3R,4R,5R,6S)-2-[[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-	(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6; (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-	C42H72O13	785.01
TCMBANKIN024355	dithiocyclopentene	288-74-4; 1,3-dithiol; 1,3-dithiole; SCHEMBL22569; CTK0J1746; AC1NSUXX; DTXSID40415715	C5H8S2	132.3 g/mol	C1CC(=C(C1)S)S
TCMBANKIN024501	1,4,6-trimethyl-1,2,3,4-tetralin			174.31
TCMBANKIN024507	1,1,5,5-tetramethyl-4-methano-2,3,4,6,7,10-hexahydronaphthalene	1,1,5,5-tetramethyl-4-methylidene-3,4a,6,7-tetrahydro-2H-naphthalene; AC1NT0Y7			CC1(CCC=C2C1C(=C)CCC2(C)C)C
TCMBANKIN024983	notoginsenosider4	notoginsenoside r4; Notoginsenoside R4; AC1NSZ7O	C59H100O27	1241.59	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)O)O)O)O)O)O)O)O)C
TCMBANKIN025024	isopulegone	Isopulegone (natural); 5-methyl-2-(1-methylethenyl)-cyclohexanone; SCHEMBL17067705; Isopulegone, (-)-; (-)-Isopulegone; ZINC100075758; Cyclohexanone, 5-methyl-2-(1-methylethenyl)-, trans- (9CI); (2S,5R)-5-METHYL-2-(PROP-1-EN-2-YL)CYCLOHEXAN-1-ONE; AHQ6120987; 2-Isopropenyl-5-methylcyclohexanone #; 17882-43-8; Cyclohexanone, 5-methyl-2-(1-methylethenyl)-, (2S-trans)-; trans-5-Methyl-2-(1-methylethenyl)cyclohexanone; 3alpha-Methyl-6beta-isopropenylcyclohexanone; 1-Isopropyl-4-methyl-2-cyclohexanone; trans-5-Methyl-2-(1-methylvinyl)cyclohexan-1-one; Cyclohexanone, 5-methyl-2-(1-methylethenyl)-, (2S,5R)-; 8(9)-p-Menthen-3-one, delta-; UNII-AHQ6120987; pulegone; RMIANEGNSBUGDJ-BDAKNGLRSA-N; 29606-79-9; p-Menth-8-en-3-one, (1R,4S)-(-)-; UNII-681XD66YSR component RMIANEGNSBUGDJ-BDAKNGLRSA-N; Cyclohexanone, 5-methyl-2-(1-methylethenyl)-, trans-; p-MENTH-8-EN-3-ONE, trans-	C10H16O	152.23 g/mol	CC1CCC(C(=O)C1)C(=C)C
TCMBANKIN025079	sanchinan-a		C53H90O45	1447.3 g/mol	C(C1C(C(C(C(O1)O)O)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)COC5C(C(C(O5)CO)O)O)O)O)O)O)O)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)O)O)O)O)O)O)O)O)O)O)O)O
TCMBANKIN025182	3(-E)-p- coumaroyl betulin
TCMBANKIN025342	Gypenoside XIV_qt	ginsenoside rb3_qt; Notoginsenoside Fe_qt	C42H72O12	769.01
TCMBANKIN025846	Mycosinol	AC1NQY4E; (3E)-3-hexa-2,4-diynylidene-4,9-dioxaspiro[4.4]nona-1,7-dien-6-ol; (2E)-2-hexa-2,4-diynylidene-1,6-dioxaspiro[4.4]nona-3,7-dien-9-ol; (2E)-2-Hexa-2,4-diynylidene-1,6-dioxaspiro(4.4)nona-3,7-dien-9-ol; NSC-653382; mycosinol; 111768-19-5; CHEBI:7038; C08455; NSC653382; CHEMBL1968944	C13H10O3	214.22	CC#CC#CC=C1C=CC2(O1)C(C=CO2)O
TCMBANKIN026213	(2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,1	(2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-methylol-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]oxy]-12-hydroxy-4,4,8,10,14-pentamethyl	C48H82O18	947.15
TCMBANKIN026694	2,4-Hexadiene, 3,4-dimethyl-, (E,Z)-	(2E,4Z)-3,4-dimethylhexa-2,4-diene; 2417-88-1; (E),(Z)-(CH3CH=C(CH3))2	C8H14	110.2	CC=C(C)C(=CC)C
TCMBANKIN026714	Cyclooctadiene	NSC105773; cycloocta-1,3-diene; InChI=1/C8H12/c1-2-4-6-8-7-5-3-1/h1-4H,5-8H2/b3-1-,4-2; cis,cis-1,3-Cyclooctadiene; NSC 105773; UN2520; 274100_ALDRICH; (1Z,3Z)-cycloocta-1,3-diene; NSC72422; (3Z)-cycloocta-1,3-diene; 1700-10-3; 1,3-Cyclooctadiene, (Z,Z)-; 29965-97-7; 29570_FLUKA; ST5409770; NSC 72422; Cyclooctadienes [UN2520] [Flammable liquid]; AI3-26696; 1,3-cyclooctadiene, (1Z,3Z)-; (1Z,3E)-cycloocta-1,3-diene; 489395_ALDRICH; 1,3-Cyclooctadiene; 3806-59-5; EINECS 216-929-1	C8H12	108.18	C1CCC=CC=CC1
TCMBANKIN027880	(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol	(2S,3R,4S,5S,6R)-2-[(1S)-1,5-dimethyl-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hex-4-enoxy]-6-methylol-tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(1S)-1,5-dimethyl-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hex-4-enoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxy-oxane-3,4,5-triol	C36H62O9	638.87	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C
TCMBANKIN029663	Exaltolide	AK103359; UNII-OK17S3S98K; Pentadecanolide, 98%; Muskalactone; Oxacyclohexadecan-2-one, 9CI, 8CI; DSSTox_CID_24359; OK17S3S98K; Oxacyclohexadecan-2-one; 1, 15-Pentadecanolide; FT-0624246; ZINC4023520; Thibetolide; Pentadecanolide; STOCK1N-01825; Pentadecanoic acid, 15-hydroxy-, laquo Xiraquo -lactone; SCHEMBL114310; Cyclopentadecanolide; Jsp000558; 1,15-Pentadecanolide; EC 203-354-6; FEMA 2840; 15-Pentadecanolide; DTXSID6044359; PENTADECALACTONE; 16-oxacyclohexadecan-1-one; Pentadecanolactone; Tox21_301123; 1,15 -pentadecanolide; NSC36763; AJ-47717; Muskolactone; FKUPPRZPSYCDRS-UHFFFAOYSA-N; DSSTox_RID_80167; NSC 36763; ANW-64867; ST50330570; MCULE-2237516421; omega-Pentadecalactone; MolPort-002-508-812; MFCD00039667; 81031-90-5; NCGC00255022-01; exaltolide; J-001527; KB-259122; AC1Q6HS8; CAS-106-02-5; RT-000456; ST2419763; 2-oxacyclohexadecan-1-one; Cyclopentadecanolactone; 1-oxacyclohexadecan-2-one; pentadecano-15-lactone; 1-Oxa-2-cyclohexadecanone; Pentalide; NCGC00248297-01; NSC-36763; P0985; Pentadecan-15-olide; CHEMBL3560504; Pentadecanolide, puriss., >=99.0% (GC); 106-02-5; AC1L5UBZ; Pentadecanoic acid, 15-hydroxy-, .xi.-lactone; BC213449; 2-Pentadecalone; Pentadecanoic acid, .xi.-lactone; 15-Pentadecanolactone; AKOS015964064; KS-00000WPF; 15-Hydroxypentadecanoic acid lactone; 15-Hydroxypentadecanoic acid, lactone; omega-Pentadecalactone, >=98%, FG; TC-153612; DSSTox_GSID_44359; AC-9864	C15H28O2	240.38	C1CCCCCCCOC(=O)CCCCCC1
TCMBANKIN030931	1,2-DIHYDRO-1,5,8-TRIMETHYLNAPHTHALENE	1,4,5-trimethyl-5,6-dialin; 1,2-dihydro-1,5,8-trimethylanaphthalene	C13H16	172.27 g/mol	CC1CC=CC2=C(C=CC(=C12)C)C
TCMBANKIN031004	wuchuyine		C10H13NO2	179.218
TCMBANKIN031239	3,3-Dimethyl allyl-p-propenyl phenyl ether	1-[(3-Methyl-2-butenyl)oxy]-4-[(1E)-1-propenyl]benzene #; 1-(3-methylbut-2-enoxy)-4-prop-1-enyl-benzene; Benzene, 1-(3-methyl-2-butenoxy)-4-(1-propenyl)-; UNII-QO3391G00A; Foeniculin, (E)-; (E)-Foeniculin; 1-(3-Methyl-2-butenyloxy)-4-(1-propenyl)benzene; 1-(3-Methyl-2-butenoxy)-4-(1-propenyl)benzene; DTXSID20228921; 1-(3-methylbut-2-enoxy)-4-prop-1-enylbenzene; 78259-41-3; QO3391G00A; JGELFJUQMIUNOO-SNAWJCMRSA-N; 1-(3-methylbut-2-enoxy)-4-[(E)-prop-1-enyl]benzene; 3,3-dimethyl allyl-p-propenyl phenyl ether; AC1NSUUD	C14H18O	202.29 g/mol	CC=CC1=CC=C(C=C1)OCC=C(C)C
TCMBANKIN031422	DICHLOROANILINE	35160_FLUKA; Dichloroanilines, liquid [UN1590] [Poison]; 2,3-Dichloranilin; InChI=1/C6H5Cl2N/c7-4-2-1-3-5(9)6(4)8/h1-3H,9H; 608-27-5; (2,3-dichlorophenyl)amine; 36701_RIEDEL; Dichloroanilines; 2,3-Dichloroaniline; 27134-27-6; 2,3-Dichlorobenzenamine; Aniline, 2,3-dichloro-; NSC60683; NCGC00163985-01; Benzenamine, 2,3-dichloro-; Benzenamine, ar,ar-dichloro-; NSC 60683; ZINC00388504; EINECS 210-157-9; ST5406286; CHEBI:46636; HSDB 5433; Aniline, 2,3-dichloro- (7CI,8CI); Ar,ar-dichlorobenzenamine; UN1590; D55407_ALDRICH; Dichloroanilines, solid [UN1590] [Poison]	C6H5Cl2N	162.02	C1=CC(=C(C(=C1)Cl)Cl)N
TCMBANKIN031470	gypenosideix	Gypenoside IX; gypenoside ix	C47H80O17	917.13	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(CO7)O)O)O)O)O)O)C
TCMBANKIN032647	Isoaloesin	7-hydroxy-5-methyl-2-(2-oxopropyl)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 7-hydroxy-5-methyl-2-(2-oxopropyl)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; 2-acetonyl-7-hydroxy-5-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; isoaloesin; 2-acetonyl-7-hydroxy-5-methyl-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; 2-acetonyl-7-hydroxy-5-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone		410.41	CC1=C2C(=CC(=C1OC3C(C(C(C(O3)CO)O)O)O)O)OC(=CC2=O)CC(=O)C
TCMBANKIN032871	3,5-dimethoxybenzoicacid		C9H10O4	182.17 g/mol	COC1=CC(=CC(=C1)C(=O)O)OC
TCMBANKIN032998	3β-o-β-d-glucopyranosyl-20-o-[α-l-arabino-pyranosyl(1→2)-β-d-glucopyranosyl]3β,12β,20(s)-trihydroxydammar-24-ene		C47H80O17		CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(CO7)O)O)O)C
TCMBANKIN033440	n-methylanthranylamide				CNC1=CC=CC=C1C(=O)N
TCMBANKIN033879	panaxatriol	(3beta,6alpha,12beta,20R)-20,25-Epoxydammarane-3,6,12-triol; Panaxatriol; UPCMLD-DP046:002; SR-05000002178-2; 32791-84-7; (20S)-Panaxatriol; NSC 308880; SR-05000002178; NCGC00161615-01; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyltetrahydropyran-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; AIDS031251; MolPort-039-338-080; Dammarane-3,6,12-triol, 20,25-epoxy-, (3.beta.,6.beta.,12.beta.,20R)-; CCG-208596; AIDS-031251; UPCMLD-DP046:001; Ambotz32791-84-7; ZINC17654227; UPCMLD-DP046; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyloxan-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; (3S,5R,6R,8R,9R,10R,12R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2R)-2,6,6-trimethyl-2-tetrahydropyranyl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol; CHEMBL1357750	C30H52O4	476.73	CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CC(C5C4(CCC(C5(C)C)O)C)O)C)O)C)C
TCMBANKIN034086	goshuyuamide- i & ii
TCMBANKIN035035	epsilon-Cadinene	AC1NST8E; (4aR)-4,7-dimethylidene-1-propan-2-yl-1,2,3,4a,5,6,8,8a-octahydronaphthalene; epsilon-cadinene	C15H24	204.35 g/mol	CC(C)C1CCC(=C)C2C1CC(=C)CC2
TCMBANKIN035097	1-Methyl-4-isoallyl-cyclohexane	1-methyl-4-[(E)-prop-1-enyl]cyclohexane; 1-methyl-4-isoallyl-cyclohexane; AC1NSYG7	C10H18	138.28	CC=CC1CCC(CC1)C
TCMBANKIN035137	(2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[oxo-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]methyl]-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-di	(2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydroxy-5-[(; (2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydrox; (2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R	C48H76O19	957.11
TCMBANKIN035440	dauricine	AKOS015965146; AC-20217; SCHEMBL677474; 524-17-4	C38H44N2O6	624.77	CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC)OC
TCMBANKIN036179	eicosylferulate	Eicosyl ferulate; (Z)-3-(4-hydroxy-3-methoxy-phenyl)acrylic acid arachyl ester; eicosyl ferulate; icosyl (Z)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoate; (Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid icosyl ester; icosyl (Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate	C30H50O4	474.7 g/mol	CCCCCCCCCCCCCCCCCCCCOC(=O)C=CC1=CC(=C(C=C1)O)OC
TCMBANKIN036312	20-Hexadecanoylingenol	20-hexadecanoylingenol	C36H58O6	586.94	CCCCCCCCCCCCCCCC(=O)OCC1=CC2C3C(C3(C)C)CC(C4(C2=O)C=C(C(C4(C1O)O)O)C)C
TCMBANKIN036500	graveoline	HMS1570G09; Graveolin; HMS2097G09; DS-19520; Prestwick2_000674; CAS-485-61-0; 2-(2H-1,3-benzodioxol-5-yl)-1-methyl-1,4-dihydroquinolin-4-one; CCG-208356; SR-01000737557; 485-61-0; 2-(1,3-Benzodioxol-5-yl)-1-methyl-4(1H)-quinolinone (graveoline); CHEMBL1371756; Prestwick1_000674; AC1L733Y; SPBio_002688; MolPort-002-511-146; 4(1H)-Quinolinone,2-(1,3-benzodioxol-5-yl)-1-methyl-; SMR000386974; 2-(1,3-benzodioxol-5-yl)-1-methylquinolin-4-one; BG00620484; MLS001048950; Prestwick_165; Oprea1_746980; Prestwick0_000674; HMS2268L04; Alkaloid from Ruta angustifolia plant; SR-01000737557-3; NSC603064; STOCK1N-10299; 2-(benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one; COBBNRKBTCBWQP-UHFFFAOYSA-N; KS-00000TWJ; CTK8G0098; NCGC00016465-01; C10689; NSC-603064; Prestwick3_000674; AK550206; AKOS002141814; 1-Methyl-2-(3,4-methylenedioxyphenyl)-4(1H)-quinolinone; NCGC00179443-01; BRD-K92683369-001-03-6; Graveoline; DTXSID80326593; 2-(1,3-Benzodioxol-5-yl)-1-methyl-4(1H)-quinolinone, 9CI; BSPBio_000767; 4(1H)-Quinolinone, 2-(1,3-benzodioxol-5-yl)-1-methyl-; CHEBI:5541; Foliosine; ZINC265501; MCULE-1487710181; NCGC00016465-02; BPBio1_000845	C17H13NO3	279.29 g/mol	CN1C2=CC=CC=C2C(=O)C=C1C3=CC4=C(C=C3)OCO4
TCMBANKIN036872	ginsenoside Rh2	ginsenoside-rh2; 78214-33-2; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-tri; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-methylol-tetrahydropyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-tr; beta-D-Glucopyranoside, (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl; ginsenoside rh 2; Ginsenoside Rg3 metabolite; ginsenoside rh-2	C36H62O8	623	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])( [H])C2([H])[H])[C@@]23C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@@]5([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])( O[H])[C@@]5([H])O[H]
TCMBANKIN036873	Ginsenoside Rd	ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6		947
TCMBANKIN036901	myristic acid	1-Tridecanecarboxylic acid; Myristinsaeure; CH3-[CH2]12-COOH; 70079_FLUKA; AI3-15381; LMFA01010014; CH3-[CH2]12-COO(-); NCGC00091068-02; Myristic acid-[9,10-3H]; C06424; Emery 655; myristic acid ; NSC 5028; 70082_FLUKA; C14 fatty acid; ST023797; W276405_ALDRICH; CCRIS 4724; Kortacid 1499; 3uev; TUNFSRHWOTWDNC-UHFFFAOYSA-M; Tetradecanoic acid; EINECS 250-924-5; n-Tetradecoic acid; 4-02-00-01126 (Beilstein Handbook Reference); Hydrofol acid 1495; MYR; BRN 0508624; Myristate; Myristic acid (natural); Tetradecanoate; LS-190125; Crodacid; Myristic acid (8CI); EINECS 208-875-2; Prifac 2942; Myristic acid; AIDS002505; tetradecoate; W276413_ALDRICH; FEMA No. 2764; HSDB 5686; Philacid 1400; CHEBI:28875; Edenor C 14; n-tetradecoate; 45184-05-2; myristicacid; tetradecoic acid; n-Tetradecanoic acid; M3128_SIGMA; AIDS-002505; Univol U 316S; Lead dimyristate; AC1N2PSK; NCGC00091068-01; neo-Fat 14; NSC5028; Tetradecanoic acid (9CI); Hystrene 9014; Myristic acid, pure; M4792_SIGMA; CHEBI:30807; n-Tetradecan-1-oic acid; WLN: QV13; 1-tetradecanecarboxylate; 32112-52-0; n-tetradecan-1-oate; 544-63-8	C14H28O2	228.371	C([H])([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]
TCMBANKIN036909	Notoginsenoside R1	A839906; notoginsenosider1; notoginsenoside r1 ; 2-(hydroxymethyl)-6-[2-[6-[6-(hydroxymethyl)-3-methyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-hept-5-en-2-yl]oxy-oxane-3,4,5-triol; oxa; (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahyd; 80418-24-2; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-methylol-3-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15; (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-oxan-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahy; C08961; 2-[2-[6-[[4,5-dihydroxy-6-(hydroxymethyl)-3-methyl-2-oxanyl]oxy]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; oxane-2,3,4; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[(2S,3R,4S,5R)-3,4,5-trihydroxy-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]oxy]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,1; (2S,3R,4S,5S,6R)-2-[(1S)-1-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,1; Notoginsenoside R1	C47H80O18	933	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])O[C@@]2([H]) O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])[C@@]5([H])O[C@@]6([H])O[C@]([H])(C([H])([H])O[H] )[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[C@@]7([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[H]
TCMBANKIN037001	alpha-Guaiene	(1S,4S,7R)-1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,4,5,6,7,8-octahydroazulene; alpha-guaiene; α-guaiene; (1S,4S,7R)-7-isopropenyl-1,4-dimethyl-1,2,3,4,5,6,7,8-octahydroazulene	C15H24	204.35 g/mol	CC1CCC(CC2=C1CCC2C)C(=C)C
TCMBANKIN037051	notoginsenoside D		C64H108O31	1374	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])O[C@@]2([H]) O[C@]([H])(C([H])([H])O[C@@]3([H])O[C@]([H])(C([H])([H])O[C@@]4([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])[C@@]([H])(O[H])[C@]([H])( O[H])[C@@]2([H])O[H])C([H])([H])C5([H])[H])[C@@]56C([H])([H])[H])[C@@]6(C([H])([H])[H])C([H])([H])C7([H])[H])[C@@]7([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@@]8([H])O[C@]([H])(C([H])([H])O[ H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]8([H])O[C@@]9([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]9([H])O[C@@]%10([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]%10([H])O[H]
TCMBANKIN037057	Arachidoside	2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(4-hydroxy-3-methoxyphenyl)-, (2R-cis)-; 3'-o-methylepicatechin; 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(4-hydroxy-3-methoxyphenyl)-, (2R,3R)-; 3'-Methylepicatechin; arachidoside; 76549-34-3; 3'-O-Methyl-(-)-epicatechin; 3'-O-METHYL EPICATECHIN; Symplocosidin; 67FI825885; (2R,3R)-2-(4-hydroxy-3-methoxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; LMPK12020111; CHEMBL2297044; SCHEMBL349242; CHEBI:70254; UNII-67FI825885		304.29 g/mol
TCMBANKIN037219	quinquenoside IV		C54H90O24	1123	C1([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C(=C([H])[C@]([H])(O[H])[C@]3(C([H])([H])[H])[C@]2([H])C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])\C([H])=C (/C([H])([H])[H])\C([H])([H])[H])O[C@@]4([H])O[C@@]([H])(C([H])([H])O[C@@]5([H])O[C@@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]5([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]4([H])O[H]) C([H])([H])C6([H])[H])[C@]36C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@@]7([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[C@@]8([H])O[C@@]([H])(C([H])([ H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]8([H])O[H]
TCMBANKIN037277	Oleanolic acid	Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid	C30H48O3	457	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H]
TCMBANKIN037364	Cyclo-(Leu-Tyr)			276.33 g/mol
TCMBANKIN037406	notoginsenoside H		C47H80O19	949	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](OC#CC#CC#C[H])(O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([ H])O[H])C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])[C@@]5([H])O[C@]6([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[C@]7([H ])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[H].[H][H].[H][H].[H][H].[H][H].[H][H]
TCMBANKIN037434	quinquenoside II		C63H106O24	1247	[C@@]1([H])(O[C@]([H])(O[C@]2([H])C([H])([H])O[H])[C@]([H])(O[C@]([H])(O[C@]3([H])C([H])([H])OC(=O)\C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])[C@]([H])(O[H])[C@@]([H])(O [H])[C@]3([H])O[H])[C@@]([H])(O[H])[C@]2([H])O[H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](C([H])([H])[H])(OC([H])([H])[C@]([H])(O[C@ ]4([H])C([H])([H])O[C@]([H])(O[C@]5([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]5([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]4([H])O[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([ H])([H])[H])C([H])([H])C6([H])[H])[C@@]67C([H])([H])[H])[C@@]7(C([H])([H])[H])C([H])([H])C8([H])[H])[C@@]8([H])C1(C([H])([H])[H])C([H])([H])[H]
TCMBANKIN037648	Lutein	SMP1_000317; (1R,4R)-4-[18-[(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexenyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-2-en-1-ol; SCHEMBL10029505; CHEBI:28838; NSC59193; (1R,4R)-4-[18-[(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexenyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethyl-1-cyclohex-2-enol; C08601; LMPR01070274; (1R,4R)-4-[18-[(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexenyl]-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethyl-cyclohex-2-en-1-ol; (1R,4R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexenyl]-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethyl-cyclohex-2-en-1-ol; lutein; 127-40-2; Xanthophyll; (3R,3'R,6'R)-beta,epsilon-carotene-3,3'-diol; BCBcMAP01_000190; (1R,4R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexenyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-2-en-1-ol; (1R,4R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethyl-1-cyclohexenyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethyl-1-cyclohex-2-enol	C40H56O2	568.87	CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2C(=CC(CC2(C)C)O)C)C)C
TCMBANKIN037651	Dehydroevodiamine	Dehydroevodiamine HCl; Dehydroevidiamine; AC1L4G2I; LS-190115; AK-693/21141027; BDBM50131047; AJ-63808; 14-Methyl-5-oxo-5,7,8,13-tetrahydro-indolo[2'',3'':3,4]pyrido[2,1-b]quinazolin-14-ium; ZINC13434330; CHEMBL81923		301.3 g/mol
TCMBANKIN037943	cyclo-(ile-ala)		C9H16N2O2	184.24 g/mol	CCC(C)C1C(=O)NC(C(=O)N1)C
TCMBANKIN038189	gypenoside XVII	Gypenoside XVII; gypenosidexvii; gypenosideXVII	C48H82O18	947	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@]([H])(O[C@]([H])(C([H])([H])O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]2([H])O[H])[C@]( [H])(O[H])[C@@]2([H])O[H])[C@@]3([H])O[H])[C@]([H])(O[H])[C@@]3([H])O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@ @]5(C([H])([H])[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]7([H])O[H])[C@]([H])(O[H])[C@@]7([H])O[H]
TCMBANKIN038261	obacunoic acid	751-29-1; obacunoic acid; obacunonic acid; DTXSID70715316; (2E)-3-[(3aS,5aR,6R,7R,9aR,9bR,10aS)-3-(Furan-3-yl)-7-(2-hydroxypropan-2-yl)-3a,6,9a-trimethyl-1,9-dioxododecahydronaphtho[2,1-c]oxireno[d]pyran-6-yl]prop-2-enoic acid; obacunoicacid; OBACUNOIC ACID; NSC314320; NSC-314320	C33H44O11	617	[C@]12([C@]([H])(OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O)O[H])[C@@]([H])(C(C([H])([H])[H])(C([H])([H])[H])OC1([H])[H])C([H])([H])C(=O)[C@]3(C([H])( [H])[H])[C@@]2([H])C([H])([H])C([H])([H])[C@@]4(C([H])([H])[H])[C@@]35[C@@]([H])(O5)C(=O)O[C@@]4([H])c6c([H])c([H])oc6[H]
TCMBANKIN038296	quinquenoside V		C60H102O28	1271	[C@@]1([H])(O[C@]([H])(O[C@]2([H])C([H])([H])O[H])[C@]([H])(O[C@]([H])(O[C@]3([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]3([H])O[H])[C@@]([H])(O[H])[C@]2([H])O[H])C([H])([H])C([H])([H])[C@ ](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](C([H])([H])[H])(O[C@]4([H])O[C@]([H])(C([H])([H])O[C@]5([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[C@@]6([H])O[C@]([ H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[H])[C@]([H])(O[H])[C@@]5([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H]) ([H])[H])C([H])([H])C7([H])[H])[C@@]78C([H])([H])[H])[C@@]8(C([H])([H])[H])C([H])([H])C9([H])[H])[C@@]9([H])C1(C([H])([H])[H])C([H])([H])[H]
TCMBANKIN038305	1-methyl-2-[(z)-5-undecenyl]-4-(1h)-quinolone	1-methyl-2-[(z)-5-undecenyl]-4(1h)-quinolone	C21H29NO	311.5 g/mol	CCCCCC=CCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN038532	δ-Cadinene	δ- cadinene		204.39
TCMBANKIN038539	δ-Guaiene	δ- guaiene
TCMBANKIN038665	Sytingaldehyde		C9H10O4	182.173	c1(O[H])c(OC([H])([H])[H])c([H])c(C([H])=O)c([H])c1OC([H])([H])[H]
TCMBANKIN039287	Panaxydol	72800-72-7; (3R)-8-[(2R,3S)-3-heptyloxiran-2-yl]oct-1-en-4,6-diyn-3-ol; panaxydol ; (3R)-8-[(2R,3S)-3-heptyl-2-oxiranyl]oct-1-en-4,6-diyn-3-ol; 1-Octene-4,6-diyn-3-ol, 8-(3-heptyloxiranyl)-; 2alpha-Heptyl-3beta-(6-hydroxy-7-octene-2,4-diynyl)oxirane		260.371
TCMBANKIN039554	hexanoic acid	(C6-C12) Alkylcarboxylic acid; n-Hexoic acid; BRN 0773837; Hexanoyl DL-carnitine; AC1O52RE; hexanoicacid; 142-62-1; Hexanoic acid (natural); n-Hexanoic acid; CCRIS 1347; Hexacid 698; 153745_ALDRICH; Hexanoic acid; 13476-79-4; 8040-17-3; 51109-46-7; AI3-07701; WLN: QV5; VVPRQWTYSNDTEA-UHFFFAOYSA-N; 19455-00-6; (C5-C9) Monobasic acids; Pentylformic acid; Hexanoyl-d,l-carnitine; Capronic acid; Butylacetic acid; Kyselina kapronova [Czech]; 4-02-00-00917 (Beilstein Handbook Reference); C01585; 1-Pentanecarboxylic acid; UN2829; 3-hexanoyloxy-4-(trimethylazaniumyl)butanoate; Fatty acids, C6-12; (C6-C12)Alkylcarboxylic acid; W255912_ALDRICH; NSC8266; CAPROIC ACID; CH3-[CH2]4-COOH; LMFA01010006; HEXANOIC ACID (CAPROIC ACID); n-Caproic acid; EINECS 267-013-3; CHEBI:30776; Hexanoylcarnitine; 68603-84-9; 70248-25-8; 21529_FLUKA; HSDB 6813; 3-(hexanoyloxy)-4-(trimethylazaniumyl)butanoate; Carboxylic acids, C5-9; NSC 8266; NCIOpen2_005355; LMFA07070070; 1-Propanaminium,3-carboxy-N,N,N-trimethyl-2-[(1-oxohexyl)oxy]-, chloride (1:1); EINECS 205-550-7; SCHEMBL235082; 1-Hexanoic acid; Pentanecarboxylic acid; Acid C-6; Carboxylic acids, C6-18 and C6-18-unsatd. mono- and C8-15-di-; H12137_ALDRICH; W255904_ALDRICH; 16571-42-9; Hexylic acid; AIDS212980; Caproic acid [UN2829] [Corrosive]; FEMA No. 2559; 67762-36-1; n-Hexylic acid; Hexoic acid; Pentiformic acid; EINECS 274-509-3; 6418-78-6; AIDS-212980; 53896-26-7; CTK4C6070; EINECS 271-676-4; Hexanoic acid ester with (3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt; CHEBI:70749; InChI=1/C6H12O2/c1-2-3-4-5-6(7)8/h2-5H2,1H3,(H,7,8; O-hexanoylcarnitine; 1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-[(1-oxohexyl)oxy]-, inner salt; 3-(hexanoyloxy)-4-(trimethylammonio)butanoate	C6H12O2	116.158	C(O[H])(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]
TCMBANKIN039620	Cyclo-(Ala-Pro)			168.19 g/mol
TCMBANKIN039839	1,3,4-Tridehydrofangchinolium hydroxide	1,3,4-tridehydrofangchinolium hydroxide	C37H39N2O6	607.78	CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6=[N+](CCC7=CC(=C(C(=C76)O3)O)OC)C)OC)OC
TCMBANKIN040012	cyclo-(phe-ala)		C12H14N2O2		CC1C(=O)NC(C(=O)N1)CC2=CC=CC=C2
TCMBANKIN040128	Echinopsine	4(1H)-Quinolinone, hydrochloride; AC1Q3BN7; 4(1H)-Quinolinone, 1-methyl-, hydrochloride; NSC-94251; NSC94251; Echinopsine hydrochloride; UNII-2607LC44K4; Echinopsine hydrochloride [MI]; 4(1H)-Quinolone, 1-methyl-, hydrochloride; 4(1H)-Quinolinone, 1-methyl-, hydrochloride (1:1); 2607LC44K4; 4(1h)-quinolinone,1-methyl-,hydrochloride; KB-304162; 4(1H)-Quinolone, hydrochloride; 1-methyl-1,4-dihydroquinolin-4-one hydrochloride; 5800-99-7		159.18
TCMBANKIN040211	Ginsenoside Rg1	ginsenosiderg1; ginsenoside r g1; sanchinoside C1; (20S)-3beta,12beta-Dihydroxy-4,4,8beta,14alpha-tetramethyl-6alpha,20-bis(beta-D-glucopyranosyloxy)-18-norcholestane-24-ene		801.01
TCMBANKIN040212	Cyclo-(Leu-Ala)			184.24 g/mol
TCMBANKIN040391	Germacrene D	C16142; (1E,6E,8S)-8-isopropyl-1-methyl-5-methylenecyclodeca-1,6-diene; (1E,6E,8S)-8-isopropyl-1-methyl-5-methylene-cyclodeca-1,6-diene; germacrene-d; (-)-Germacrene D; (1E,6E,8S)-1-methyl-5-methylidene-8-propan-2-yl-cyclodeca-1,6-diene; germacrene d; Germacrene- D; GermacreneD; (1E,6E,8S)-1-methyl-5-methylidene-8-propan-2-ylcyclodeca-1,6-diene; nchembio.2007.29-comp4	C15H24	204.351	C1([H])([H])C(=C([H])[H])\C([H])=C([H])\[C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])\C(\C([H])([H])[H])=C([H])\C1([H])[H]
TCMBANKIN040419	panaxytriol	(3R,9S,10S)-Panaxytriol; SCHEMBL87655; heptadeca-1-ene-4,6-diyne-3,9,10-triol; Panaxytriol	C17H26O3	278.39	CCCCCCCC(C(CC#CC#CC(C=C)O)O)O
TCMBANKIN040444	ginsenoside rc	2-[[2-[[17-[2-[[6-[[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]oxymethyl]-3,4,5-trihydroxy-2-oxanyl]oxy]-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,10,14-tetramethyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydr; ginsenosiderc; I06-0733; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-[[5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,10,14-tetramethyl-12-oxidanyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocy; A802167	C53H90O22	1079.27	CC(=CCCC(C)(C1CCC2(C1C(CC3C2CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C
TCMBANKIN041090	1-methyl-2-[(z)-9-pentadecenyl]-4-(1h)-quinolone	1-methyl-2-[(z)-9-pentadecenyl]-4(1h)-quinolone	C25H37NO	367.6 g/mol	CCCCCC=CCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN041265	β,β-Dimethylacrylalkannin	beta,beta-dimethylacrylalkannin		370.4 g/mol
TCMBANKIN041272	stearic acid	4-02-00-01206 (Beilstein Handbook Reference); AIDS-049230; Emersol 871; 8039-52-9; 126539-56-8; stearic acid, ion(1-); D00119; octadecoic acid; Hydrofol Acid 150 (VAN); 134503-33-6; Fatty acids C16-18; 68937-76-8; Kam 2000; VLZ 200; Lunac S 98; Glycon S-80; Hy-phi 1205; Lunac YA; Pristerene 9429; Pristerene 4900; Octadecanoic acid (9CI); Hystrene 9718NF; Edenor FHTI; Cetylacetic acid; NAA 173; NSC 25956; Lunac S 90; S 30C S 30C (fatty acid); Neo-Fat 18-61; Dar-chem 14; NSC25956; Edenor HT-JG 60; Octadecanoate; 57485-56-0; Oktadekansaeure; S 300 (fatty acid); Unister NAA 180; Industrene 5016; Prisorine 3508; Hydrofol Acid 150; Hystrene 4516; G 270; Stearic Acid Cherry; Century 1230; 822-16-2 (SODIUM SALT); NCGC00091596-02; Glycon S-90; 85404-83-7; NCGC00091596-01; Stearic acid (JP15/NF); Hystrene 5016; Hy-phi 1303; Glycon S-70; C01530; Octadecansaeure; Neo-Fat 18-55; WO 2 (fatty acid); Pristerene 9559; SA 200; Century 1240; Stearic acid, pure; Sunfat 18S; WO 2; CHEBI:28842; Industrene 5016K; LS-2392; Kam 3000; BRN 0608585; Edenor ST 20; AIDS049230; Lunac 30; EINECS 273-087-8; Emersol 150; 175366_SIAL; 8039-54-1; Fatty acids, C16-20; stearicacid; Stearic acid ion(1-)salt; Stearic acid (8CI); Stearinsaeure; Emersol 153NF; Hydrofol acid 1855; 57-11-4; Lunac S 30; Hystrene T 70; Prisorine 3501; Haimaric MKH(R); Stearex Beads; Groco 55; Hystrene S-97; Neo-Fat 18-54; W303518_ALDRICH; Hydrofol acid 1655; Nonsoul SN 1 (Sodium salt); EINECS 200-313-4; 39390-61-9; Emersol 120; EPA Pesticide Chemical Code 079082; Lunac S 20; Octadecanoic acid, ion(1-); 8013-28-3; AI3-00909; Kortacid 1895; FEMA No. 3035; Hystrene S 97; 82497-27-6; Tegostearic 254; SNA-2000 (Sodium salt); 1-Heptadecanecarboxylic acid; AC1MHWEJ; STL280244; 27405_RIEDEL; Steric acid; Industrene 9018; Glycon dp; F 3 (lubricant); Hy-phi 1401; Lunac S 50; Emersol 132; Stearic acid, ion(1-) (8CI); CH3-[CH2]16-COO(-); acide octadecanoique; Groco 55l; 73297_FLUKA; Serfax MT 90; Stearic acid [USAN:JAN]; 8039-51-8; acide stearique; Kam 1000; Acidum stearinicul; InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20; 8039-53-0; 17FA; Stearophanic acid; 8037-83-0; Hystrene 7018; FA 1655; Prisorine 3502; Nonsoul SK 1; Hydrofol Acid 1895; Lunac S 40; Stearic acid 50; 8023-06-1; 85679_FLUKA; HSDB 2000; n-Octadecanoate; 400JB9103-88; Glycon tp; Unimac 5680; Loxiol G 20; Stearate; 875D; Octadecanoic acid; Neo-Fat 18-53; octadecanoate (n-C18:0); Radiacid 0427; Emery 871; Vanicol; Vis-Plus; PD 185; EINECS 250-178-0; AKOS022105769; 646-29-7; Edenor ST 1; S 300; Caswell No. 801D; Selosol 920; Tegostearic 272; Isostearic acid EX; A 1760; WLN: QV17; Stearic acid (TN); Pearl stearic; 609343-71-7; Palmitic acid - stearic acid mixture; Emersol 875; Industrene 8718; Hystrene 9718NFFG; NCGC00164255-02; ST023799; LMFA01010018; Groco 54; Edenor C18; Hystrene T-70; Hy-phi 1199; CTK8J8420; n-Octadecanoic acid; Groco 58; Pristerene 4963; Formula 300; AFCO-Chem B 65; CCRIS 2305; Industrene R; Century 1220; S4751_SIGMA; Neo-Fat 18; 58392-66-8; Barolub FTA; Hystrene 9718; CH3-[CH2]16-COOH; STE; 8037-40-9; 30399-84-9; Lunac S 90KC; Hydrofol 1895; Emery 875D; Century 1210; QIQXTHQIDYTFRH-UHFFFAOYSA-M; Neo-Fat 18-59; LS-1388; Groco 59; Humko Industrene R; Hystrene 80; Adeka Fatty Acid SA 910; Stearic acid; Prifac 2918; Emersol 6349; Edenor C 18/98; 3uex; LS-97707; CHEBI:25629; Neo-Fat 18-S; Stearic acid - palmitic acid mixture; Tegostearic 255; C-Lube 10	C18H36O2	284	C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])= O
TCMBANKIN041320	cyperene	Cyperene; 2387-78-2; (-)-cyperene; LMPR0103450002; α-cyperene; 3H-3a,7-Methanoazulene, 2,4,5,6,7,8-hexahydro-1,4,9,9-tetramethyl-, (3aR-(3aalpha,4beta,7alpha))-	C15H24	204.351	C1([H])([H])C([H])([H])C(C([H])([H])[H])=C2[C@@]13C(C([H])([H])[H])(C([H])([H])[H])[C@]([H])(C2([H])[H])C([H])([H])C([H])([H])[C@@]3([H])C([H])([H])[H]
TCMBANKIN041461	Cyclo-(Leu-Ile)			226.32 g/mol
TCMBANKIN041496	cyclo-(leu-thr)		C10H18N2O3		CC(C)CC1C(=O)NC(C(=O)N1)C(C)O
TCMBANKIN041672	ginsenoside Rf	(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; C08945; (2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; ginsenoside r f; ginsenoside-rf; Ginsenoside Rf; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; ginsenosiderf; 52286-58-5; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6	C42H72O14	801	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])(O[H])C([H])([H])[H])C([H])( [H])C2([H])[H])[C@@]23C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])[C@]4([H])O[C@@]5([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]5([H])O[C@@]6([H])O[C@@]([H])(C([H])([H])O[H] )[C@]([H])(O[H])[C@@]([H])(O[H])[C@]6([H])O[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H]
TCMBANKIN042311	(S)-Dencichine
TCMBANKIN042337	Ditertbutyl phthalate	Di-(terc-butilperoxi)ftalato; 30448-43-2; SCHEMBL109178; DTXSID10184527; EINECS 250-204-0; benzene-1,2-dicarboxylic acid ditert-butyl ester; Diperoxyphtalate de tert-butyle; 1,2-Benzenedicarboxylicacid, 1,2-bis(1,1-dimethylethyl) ester; AC1L3T9P; ditertbutyl phthalate; AKOS030616148; CTK4G5219; AK661164; Phthalic acid ditert-butyl ester; Peroxyphthalic acid, di-tert-butyl ester (8CI); Di-(tert-butylperoxy) phthalate, >55% in solution; AC1Q5XKL; ditert-butyl benzene-1,2-dicarboxylate; ZINC5353715; Di-tert-butyl phthalate; ACM30448432; 1,2-DI-TERT-BUTYL PHTHALATE; 134115-67-6	C16H22O4	278.34	CC(C)(C)OC(=O)C1=CC=CC=C1C(=O)OC(C)(C)C
TCMBANKIN042413	Notoginsenoside B			1123.3 g/mol
TCMBANKIN042614	quinquenoside III		C50H84O19	989	[C@@]1([H])(O[C@]([H])(O[C@]2([H])C([H])([H])OC(C([H])([H])[H])=O)[C@]([H])(O[C@]([H])(O[C@]3([H])C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]3([H])O[H])[C@@]([H])(O[H])[C@]2([H])O[H])C([H])([H ])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](C([H])([H])[H])(O[C@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H]) C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]56C([H])([H])[H])[C@@]6(C([H])([H])[H])C([H])([H])C7([H])[H])[C@@]7([H])C1(C([H])([H])[H])C([H])([H])[H]
TCMBANKIN042955	Notoginsenoside M			963.2 g/mol
TCMBANKIN043074	notoginsenoside N		C48H82O19	963	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@@]2([H])O[C@@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]2([H])O[H])(C([H] )([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])[C@]5([H])O[C@@]6([H])O[C@]([H])(C([H])([H])O[H]) [C@@]([H])(O[C@@]7([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[C@]([H])(O[H])[C@@]6([H])O[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H]
TCMBANKIN043169	Cyclo-(Ala-Val)
TCMBANKIN043264	notoginsenoside K		C48H82O18	947	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](C([H])([H])[H])(O[C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2 ([H])O[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H ])[H])[C@@]1([H])O[C@]6([H])O[C@]([H])(C([H])([H])O[C@]7([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]7([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[H]
TCMBANKIN043280	notoginsenoside J		C42H74O16	835	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@@]2([H])O[C@@]([H])(C([H])([H])O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]2([H])O[H])(C([H] )([H])[H])C([H])([H])C([H])([H])[C@]([H])(O[H])C(O[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C3([H])[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])[C@]5([H])O[C@@]6([H])O[C@]([H])(C([H] )([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]6([H])O[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H]
TCMBANKIN043364	Evodianinine
TCMBANKIN043469	γ-Elemene	O-Menth-8-ene, 4-isopropylidene-1-vinyl-; 1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-methylethylidene)-cyclohexane; γ- elemene; γ--elemene; γ-Elernene		204.35
TCMBANKIN043534	Notoginsenoside Fe	notoginsenoside fe	C47H80O17	917.13	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(O7)CO)O)O)O)O)O)C
TCMBANKIN043634	notoginsenoside g		C48H80O19	961.1 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(C(C=C4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C
TCMBANKIN043658	12alpha-Hydroxyevodol	12alpha-hydroxyevodol; 12α-hydroxyevodol	C26H28O10	500.5 g/mol	CC1(C2=C(C(=O)C3(C(C24COC(=O)CC4O1)CC(C5(C36C(O6)C(=O)OC5C7=COC=C7)C)O)C)O)C
TCMBANKIN043716	Picein	picein; 1-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethanone; C10720; 1-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxyphenyl]ethanone; 1-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]ethanone; 1-(4-(beta-D-Glucopyranosyloxy)phenyl)ethan-1-one; 530-14-3; EINECS 208-473-7; 1-[4-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]phenyl]ethanone		298.289
TCMBANKIN043775	cycloeucalenol	4alpha,14-dimethyl-9beta,19-cyclo-5alpha-ergost-24(28)-en-3beta-ol; 9,19-Cycloergost-24(28)-en-3-ol, 4,14-dimethyl-, (3beta,4alpha,5alpha)-; 469-39-6; C02141; AKOS032948711; cycloleucalenol; CHEBI:16653; cycloeucalenol; 3beta,4alpha,5alpha-4,14-dimethyl-9,19-cycloergost-24(28)-en-3-ol	C30H50O	427	[C@]1([H])(O[H])[C@@]([H])(C([H])([H])[H])[C@@]2([H])[C@@]3([C@@]4(C3([H])[H])[C@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@@]5([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])C(=C([H])[H])C( [H])(C([H])([H])[H])C([H])([H])[H])[H])[C@]5(C([H])([H])[H])C([H])([H])C4([H])[H])C([H])([H])C2([H])[H])C([H])([H])C1([H])[H]
TCMBANKIN043982	Gravacridoneshlirine	gravacridoneshlirine	C19H18ClNO4	359.804	c1([H])c([H])c(N(C([H])([H])[H])c(c(C([H])([H])[C@]([H])([C@](C([H])([H])[H])(Cl)C([H])([H])O[H])O2)c2c([H])c3O[H])c3C4=O)c4c([H])c1[H]
TCMBANKIN044254	Notoginsenoside A	AC1O52SM; .beta.-D-Glucopyranoside, (3.beta.,12.beta.)-20-[(6-O-.beta.-D-glucopyranosyl-.beta.-D-glucopyranosyl)oxy]-12,25-dihydroxydammar-23-en-3-yl 2-O-.beta.-D-glucopyranosyl-; Notoginsenoside A; 193895-21-5; beta-D-Glucopyranoside, (3beta,12beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12,25-dihydroxydammar-23-en-3-yl 2-O-beta-D-glucopyranosyl-		1125.3 g/mol
TCMBANKIN044577	notopterol	AX8245234; 4-[(2E)-5-hydroxy-3,7-dimethylocta-2,6-dienoxy]furo[3,2-g]chromen-7-one; CHEMBL258939; MFCD23701669; Notopterol; ST24035054; 4CH-024741; AK119818; CHEBI:81136; C17499; MolPort-027-836-284; (E)-4-((5-Hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy)-7H-furo[3,2-g]chromen-7-one; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-((5-hydroxy-3,7-dimethyl-2,6-octadienyl)oxy)-, (E)-; AC1NSZ7R; BG01067911; BDBM50375219; 88206-46-6; 4-{[(2E)-5-HYDROXY-3,7-DIMETHYLOCTA-2,6-DIEN-1-YL]OXY}FURO[3,2-G]CHROMEN-7-ONE; KB-209244; AKOS016010745; 5[(2E)-5-hydroxy-3,7-dimethyl-2,6-octadienyloxy]psoralen	C22H24O4	352.424	c12c(oc([H])c1[H])c([H])c3c(C([H])=C([H])C(=O)O3)c2OC([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[C@]([H])(C([H])([H])[H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H]
TCMBANKIN044583	cyclo-(phe-val)		C14H18N2O2	246.3 g/mol	CC(C)C1C(=O)NC(C(=O)N1)CC2=CC=CC=C2
TCMBANKIN044770	Jangomolide			468.5 g/mol
TCMBANKIN044942	Quercetin-3-L-arabinon-7-D-glucoside	Quercetin-3-L-arabinon-7-D-glucoside; Quercetin-3-O-malonyl-beta-D-glucoside; quercetin-3-l-arabinon-7-d-glucoside	C26H28O17	464.38	c1([H])c(O[H])c(C(=O)C(O[C@]2([H])O[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]2([H])O[H])=C(c3c([H])c(O[H])c(O[H])c([H])c3[H])O4)c4c([H])c1O[C@]5([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])( O[H])[C@@]([H])(C([H])([H])O[H])O5
TCMBANKIN045517	Methyl 3,3,6-tri-O-galloyl-beta-D-glucopyranoside	methyl 3,3,6-tri-o-galloyl-beta-d-glucopyranoside	C28H26O18	650.54	c1(O[H])c(O[H])c([H])c(C(=O)OC([H])([H])[C@@]2([H])O[C@]([H])(OC([H])([H])[H])[C@]([H])(OC(c3c([H])c(O[H])c(O[H])c(O[H])c3[H])=O)[C@@]([H])(OC(c4c([H])c(O[H])c(O[H])c(O[H])c4[H])=O)[C@]2([H])O[H])c([H ])c1O[H]
TCMBANKIN045610	1-Methyl-2-dodecyl-4-(1H)-quinolone	2-dodecyl-1-methylquinolin-4-one; 1-Methyl-2-dodecyl-4(1H)-quinolone; 1-methyl-2-dodecyl-4(1h)-quinolone; AC1NSYC8	C22H33NO	327.504	c1([H])c([H])c(C(=O)C([H])=C(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])N2C([H])([H])[H])c2c([H])c1[H]
TCMBANKIN046177	cyclo-(leu-val)		C11H20N2O2	212.29 g/mol	CC(C)CC1C(=O)NC(C(=O)N1)C(C)C
TCMBANKIN046440	evodiaxinine		C20H15N3O
TCMBANKIN046580	methyl pyroglutamate		C6H9NO3	143.141	C1([H])([H])C([H])([H])[C@]([H])(C(OC([H])([H])[H])=O)N([H])C1=O
TCMBANKIN046749	rutaevin	Rutaevin; rutaevin ; C08779; 33237-37-5	C26H30O9	487	O1[C@@]([H])(C([H])([H])C(=O)OC2([H])[H])[C@]2([C@@]([H])(C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])[C@@]45[C@]([H])(O4)C(=O)O[C@@]3([H])c6c([H])c([H])oc6[H])[C@@]5(C([H])([H])[H])[C@]([H])(O[H])C7=O )[C@@]7([H])C1(C([H])([H])[H])C([H])([H])[H]
TCMBANKIN046802	notoginsenoside C		C55H94O25	1155	C([H])([H])(O[H])[C@@]1([H])O[C@](O[C@@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@@]([C@]([C@@](C([H])([H])[H])(O[C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[ H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[C@@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])O3)C([H])([H])C([H])([H])[C@]([H])(OO[H])C(C([H])([H])[H])=C([H])[H])([H]) C([H])([H])C5([H])[H])([H])[C@@]56C([H])([H])[H])[C@@]6(C([H])([H])[H])C([H])([H])C7([H])[H])[C@]7([H])C2(C([H])([H])[H])C([H])([H])[H])([H])[C@]([H])(O[C@@](C([H])([H])[H])([C@]([H])(O[H])[C@@]8([H]) O[H])O[C@]([H])(C([H])([H])O[H])[C@@]8([H])O[H])[C@@]([H])(O[H])[C@]1([H])O[H]
TCMBANKIN046962	Rutaevine	rutaevine	C25H28O9	472.53	C1(=O)OC([H])([H])[C@@]2([C@]([H])(C(C([H])([H])[H])(C([H])([H])[H])O3)C(=O)[C@]([H])(O[H])[C@]4(C([H])([H])[H])[C@]2([H])C([H])([H])C([H])([H])[C@@]5([H])[C@]46[C@]([H])(O6)C(=O)O[C@@]5([H])c7c([H])o c([H])c7[H])[C@@]3([H])C1([H])[H]
TCMBANKIN047056	Cyclo-(Pro-Val)			196.25 g/mol
TCMBANKIN047183	Cyclo-(Leu-Ser)
TCMBANKIN047281	Notoginsenoside L			1079.3 g/mol
TCMBANKIN048156	cyperol	CHEMBL2268862; APWLDLGOYJHNIK-YUELXQCFSA-N; C16945; 20084-99-5; DTXSID70555532; (2R,4aS,7R)-1,4a-Dimethyl-7-(prop-1-en-2-yl)-2,3,4,4a,5,6,7,8-octahydronaphthalen-2-ol; 3ALPHA-HYDROXY-CYPERONE; Cyperol; CHEBI:80813	C15H24O	220.35	CC1=C2CC(CCC2(CCC1O)C)C(=C)C
TCMBANKIN048280	Notoginsenoside I			1093.3 g/mol
TCMBANKIN048530	quinquenoside i		C52H86O19	1015.2 g/mol	CC=CC(=O)OCC1C(C(C(C(O1)OC2C(C(C(OC2OC3CCC4(C(C3(C)C)CCC5(C4CC(C6C5(CCC6C(C)(CCC=C(C)C)OC7C(C(C(C(O7)CO)O)O)O)C)O)C)C)CO)O)O)O)O)O
TCMBANKIN048691	alpha-Guttiferin	alpha-guttiferin	C27H32O6	452.59	C1(C([H])([H])[H])=C(C([H])([H])[H])c2c(c(C(=O)C(\C(=C(/C([H])([H])C([H])([H])[H])\O[H])\[C@@]([H])(C([H])([H])[H])C([H])([H])C3([H])[H])=C3[H])c(O[H])c(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H ])[H])c2O[H])OC1=O
TCMBANKIN049105	acetonylevodiamine		C22H21N3O2
TCMBANKIN049364	6-o-β-d-glucopyranosyl-5-hydroxyangelicin		C17H16O10		C1=CC(=O)OC2=C1C(=C(C3=C2C=CO3)OC4C(C(C(C(O4)CO)O)O)O)O
TCMBANKIN049472	sanchinoside b1		C36H62O9	638.9 g/mol	CC(=CCCC(C)(C)O)C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C
TCMBANKIN049515	cyclo-(phe-tyr)		C18H18N2O3	310.3 g/mol	C1=CC=C(C=C1)CC2C(=O)NC(C(=O)N2)CC3=CC=C(C=C3)O
TCMBANKIN049605	1-methyl-2-[(z)-10-pentadecenyl]-4-(1h)-quinolone	1-methyl-2-pentadec-10-enyl-4(1h)-quinolone; AC1O3DPF; 1-methyl-2-pentadec-10-enylquinolin-4-one; 120693-50-7; 1-methyl-2-[(z)-10-pentadecenyl]-4(1h)-quinolone; ACMC-20mp2i; CTK0F8623; 4(1H)-Quinolinone, 1-methyl-2-(10Z)-10-pentadecenyl-; DTXSID00422526	C25H37NO	367.6 g/mol	CCCCC=CCCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN050143	4,4'-Diketo-3-hydroxy-beta-carotene	beta,beta-Carotene-4,4/'-dione, 3-hydroxy-; 3-Hydroxycanthaxanthin; beta-Carotene-4,4'-dione, 3-hydroxy-, all-trans-; Phenicoxanthin; 3-Hydroxy-beta,beta-carotene-4,4'-dione; SCHEMBL149807; 4418-72-8; beta,beta-Carotene-4,4'-dione, 3-hydroxy-; 4,4'-diketo-3-hydroxy-β-carotene; 3-Hydroxy-4,4'-diketo-beta-carotene; All-trans-adonirubin; 4,4'-Diketo-3-hydroxy-beta-carotene	C40H52O3	580.8 g/mol	[C@]1([H])(O[H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C(\C([H])=C([H])\C(\C([H])([H])[H])=C([H])/C([H])=C([H])\C(\C([H])([H])[H])=C([H])\C([H])=C([H])\C([H])=C(/C([H])([H])[H])\C([H])=C([H])\C([ H])=C(/C([H])([H])[H])\C([H])=C([H])\C2=C(C([H])([H])[H])C(=O)C([H])([H])C([H])([H])C2(C([H])([H])[H])C([H])([H])[H])=C(C([H])([H])[H])C1=O
TCMBANKIN050180	Isobutyl pyroglutamate
TCMBANKIN050354	1-Methyl-2-(Z)-8-tetradecenyl-4(1H)-quinolone
TCMBANKIN057925	l-α-amino-β-oxalylaminopropionicacid	N(3)-(carboxylatoformyl)-L-2,3-diaminopropionate(1-); N3-oxalyl-L-2,3-diaminopropionic acid; (2S)-2-ammonio-3-[(carboxylatocarbonyl)amino]propanoate; beta-N-Oxalyl-L-alpha,beta-diaminopropionate; N-3-oxalyl-L-2,3-diaminopropanoate; (2S)-2-azaniumyl-3-(carboxylatoformamido)propanoate; CHEBI:57758; l-alpha-amino-beta-oxalylaminopropionic acid; N3-Oxalyl-L-2,3-diaminopropanoate; (2S)-2-azaniumyl-3-[(carboxylatocarbonyl)amino]propanoate; L-alpha-Amino-beta-oxalylaminopropionic acid; N(3)-oxalyl-L-2,3-diaminopropanoate	C5H7N2O5-	175.12 g/mol	C(C(C(=O)[O-])[NH3+])NC(=O)C(=O)[O-]
TCMBANKIN057973	NSC405997	22513-81-1; 1,22-Docosanediol; AIDS-471012; AIDS471012; docosane-1,22-diol;DTXSID00324197; CTK1A7857; AKOS028111015; 1,22-Docosanediol; MCULE-8562052651; AC1L873A; SCHEMBL472790; CHEMBL470773; NSC-405997; HIBKFQRBONXURO-UHFFFAOYSA-N; NSC405997; 1,22-hexadecanediol; docosane-1,22-diol;1,22-docosanediol	C22H46O2	342.6 g/mol	C(CCCCCCCCCCCO)CCCCCCCCCCO
TCMBANKIN058629	rutacarpine	rutaecarpine;rutecarpine	C18H13N3O	287.3 g/mol	C1CN2C(=NC3=CC=CC=C3C2=O)C4=C1C5=CC=CC=C5N4
TCMBANKIN058630	14-formyldihydro rutaecarpine	14-formyldihydrorutaecarpine	C19H15N3O2	317.3 g/mol	C1CN2C(C3=C1C4=CC=CC=C4N3)N(C5=CC=CC=C5C2=O)C=O
TCMBANKIN058635	1,2,3,4-tetrahydro-1-oxo-β-carboline	1,2,3,4-tetrahydrol-oxo-beta-carboline	C11H10N2O		C1CNC(=O)C2=C1C3=CC=CC=C3N2
TCMBANKIN058638	higenamine	UNII-6016M93W29; CHEBI:27751; (R)-Norcoclaurine; 6,7-Dihydroxy-(1R)-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (1R)-; (1R)-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol; 6016M93W29; SCHEMBL5898913; AX8328517; DTXSID90331552; (+)-HIGENAMINE; UNII-TBV5O16GAP component WZRCQWQRFZITDX-CQSZACIVSA-N; CHEMBL501778; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (R)-; C06347; (R)-(+)-Higenamine; (+)-Demethylcoclaurine; 106032-53-5; BDBM50242856; AC1L9ACA; (1R)-1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; AK00743742; (R)-1-(4-Hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; Higenamine, (+)-; ZINC896041; demethylcoclaurine; demetahyl coclaurine	C16H17NO3	271.31 g/mol	C1CNC(C2=CC(=C(C=C21)O)O)CC3=CC=C(C=C3)O
TCMBANKIN058661	C08464	2060-59-5; Tridec-1-ene-3,5,7,9,11-pentayne; 1-Tridecene-3,5,7,9,11-pentyne; 1-Tridecen-3,5,7,9,11-pentayne; tridec-1-en-3,5,7,9,11-pentayne; 1-Tridecene-3,5,7,9,11-pentayne;1-tridecene-3,5,7,9,11-pentyne	C13H6	162.19 g/mol	CC#CC#CC#CC#CC#CC=C
TCMBANKIN058681	1,1-Dimethyl-2-(3-methyl-1,3-butadiene)-cyclo-propane	1,1-dimethyl-2-(3-methyl-1,3-butadiene)-cyclo-propane; 1,1-dimethyl-2(3-methyl-1,3-butadienyl)-cyclopropane	C10H16	136.26	CC(=C)C=CC1CC1(C)C
TCMBANKIN058761	(E)ocimene	(E)- ocimene; (E)-ocimene;p-Ocimene;3,7-Dimethyl-1,3,6-octatriene;trans-ocimene;trans- beta- Ocimene;ocimene;β-trans-ocimene;3,7-dimethyl-1,3e,6-octatriene;3,7-Dimethylocta-1,3,6-triene; 3,7-Dimethyl-1,3,6-octatriene (natural); beta-trans-Ocimene; EINECS 223-241-5; 74730_FLUKA; 11009-78-2; ST5410145; 3,7-Dimethyl-1,3,6-octatrien; 27400-72-2; FEMA No. 3539; 3,7-DIMETHYL-1,3,6-OCTATRIENE; (E)-3,7-Dimethyloctatriene; 1856-63-9; 11022-64-3; EINECS 237-641-2; BETA-OCIMENE, TRANS; 1,3,6-Octatriene, 3,7-dimethyl-, (E)-; .beta.-trans-Ocimene; 13877-91-3; .beta.-Ocimene; Octatriene, 3,7-dimethyl-, (E)-; beta-Ocimene; trans-beta-Ocimene; 1,3,6-Octatriene, 3,7-dimethyl-; Ocimene, beta-; 3779-61-1; (E)-3,7-Dimethylocta-1,3,6-triene; Ocimene trans-beta-form; (3E)-3,7-dimethylocta-1,3,6-triene; C09873;trans-β-Oci-mene; Trans- β- ocimene; trans-beta-ocimene;EINECS 249-805-0; AC1O5HAL; LS-98065; (3E,5E)-3,7-dimethylocta-1,3,5-triene; 2,6-Dimethyloctane, hexadehydro derivative; 29714-87-2; Dimethyloctatriene (mixed isomer);beta-trans-ocimene;3,7-Dimethylocta-1,3,6-triene; 3,7-Dimethyl-1,3,6-octatriene (natural); beta-trans-Ocimene; EINECS 223-241-5; 74730_FLUKA; 11009-78-2; ST5410145; 3,7-Dimethyl-1,3,6-octatrien; 27400-72-2; FEMA No. 3539; 3,7-DIMETHYL-1,3,6-OCTATRIENE; (E)-3,7-Dimethyloctatriene; 1856-63-9; 11022-64-3; EINECS 237-641-2; BETA-OCIMENE, TRANS; 1,3,6-Octatriene, 3,7-dimethyl-, (E)-; .beta.-trans-Ocimene; 13877-91-3; .beta.-Ocimene; Octatriene, 3,7-dimethyl-, (E)-; beta-Ocimene; trans-beta-Ocimene; 1,3,6-Octatriene, 3,7-dimethyl-; Ocimene, beta-; 3779-61-1; (E)-3,7-Dimethylocta-1,3,6-triene; Ocimene trans-beta-form; (3E)-3,7-dimethylocta-1,3,6-triene; C09873;ci-mene; Trans- β- ocimene; trans-beta-ocimene;EINECS 249-805-0; AC1O5HAL; LS-98065; (3E,5E)-3,7-dimethylocta-1,3,5-triene; 2,6-Dimethyloctane, hexadehydro derivative; 29714-87-2; Dimethyloctatriene (mixed isomer);beta-trans-ocimene	C10H16	136.23 g/mol	CC(=CCC=C(C)C=C)C
TCMBANKIN058854	protopanaxtriol	(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6,12-triol	C30H52O4	476.73 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)O)C
TCMBANKIN058858	ginsenoside- Rg1	ginsenoside-rg1;(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H; (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a; (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclop; (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[; C08946; (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-; 22427-39-0; sanchinoside rg1; Sanchinoside C1	C42H72O14	801.01 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C
TCMBANKIN058859	Notoginsenoside R6	notoginsenoside r6	C48H82O19	963.2 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)O)O)O)C
TCMBANKIN058860	ginsenoside rf	2α,3β,12β,20(s)-3-hydroxydammar-24-en-20-o-β-d-glucopyranoside; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; C08945; (2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; ginsenoside r f; ginsenoside-rf; Ginsenoside Rf; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-; ginsenosiderf; 52286-58-5; (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6	C42H72O14	801.01	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)O)C
TCMBANKIN058861	ginsenoside rd;20-glucosylginsenosiderf;20-glucosylginsenosiderf	ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6;(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(6S,14R)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; 20-glucosylginsenoside rf; AC1O3DDF;;20-glucosylginsenosiderf;20-glucosylginsenosiderf	C48H82O18	947.15	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C
TCMBANKIN058863	20-o-β-d-xylopyranosyl(1→6)-β-d-gluco-pyranosyl-20(s)-protopanaxadiol				CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)OC5C(C(C(C(O5)COC6C(C(C(CO6)O)O)O)O)O)O)C
TCMBANKIN058865	ginsenoside-F2	ginsenoside- F2; ginsenoside f2	C42H72O13	785.01	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C
TCMBANKIN058867	ginsenoside rb1	Q-100470; A-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl ; GRb 1; MFCD00133367; ginsenosiderb1; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root, triterpenoid saponin; beta-D-Glucopyranoside, (3-beta,12-beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-; N1620; NSC 310103; CHEBI:67989; Ginsenoside Rb1, primary pharmaceutical reference standard; C20713; Panax saponin E; 7413S0WMH6; Pseudoginsenoside D; 87700-07-0; A-Glucopyranosyl-(3; C54H92O23; A)-20-[(6-O-; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl-beta-D-glucopyranoside; Ginsenoside Rb1, European Pharmacopoeia (EP) Reference Standard; (3beta,12beta)-20-{[6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; 20(S)-ginsenoside Rb1; 2-O-; Ginsenoside Rb1 (saponin of panax ginseng); 52286-61-0; 12770-17-1; 393829-67-9; CS-3829; BIDD:ER0108; A,12; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl beta-D-glucopyranoside; GZYPWOGIYAIIPV-JBDTYSNRSA-N; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root; GS-Rb1; 41753-43-9; ginsenoside-rb1; ginsenoside r b1; 212055-66-8; UNII-7413S0WMH6; AB0016710; AKOS025311537; A-D-glucopyranoside; Ginsenoside rb1; MolPort-016-638-397; gensenoside Rb1; Gypenoside III; ginsenoside Rb1; CHEMBL501515; HY-N0039; Gynosaponin C; BDBM50317541; (3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; Ambap41753-43-9; GSRb1; Ginsenoside-Rb1; 753G439; Sanchinoside E1; A-D-glucopyranosyl-; Panaxsaponin E; O899; ginsenoside-Rb1;gypenosideIII	C54H92O23	1109.3 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C
TCMBANKIN058869	ginsenoside Rb3	ginsenoside rb3; ginsenoside r b3; gensenoside- Rb3; ginsenoside- Rb3; gensenoside Rb3; ginsenosiderb3; ginsenoside-rb3	C53H90O22	1079.3 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C
TCMBANKIN058880	dammarenediol II	dammar-24-ene-3β,20-diol i;dammarane type;ginsenoside;74749-74-9; UNII-3K198YD54P; LS-71251; (3S,5R,8R,9R,10R,14R,17S)-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; 3K198YD54P; Ginsenosides; AC1MJ5EP	C30H52O2	444.73	CC(=CCCC(C)(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)O)C)C)C)O)C
TCMBANKIN058928	1-(5,7,8-trimethoxy-2,2-dimethylchromen-6-yl)ethanone	1-(5,7,8-trimethoxy-2,2-dimethyl-chromen-6-yl)ethanone; 1-(5,7,8-trimethoxy-2,2-dimethyl-6-chromenyl)ethanone; Ethanone, 1-(5,7,8-trimethoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-; Ketone, methyl 5,7,8-trimethoxy-2,2-dimethyl-2H-1-benzopyran-6-yl	C16H20O5;C26H30O9	292.33 g/mol	CC(=O)C1=C(C2=C(C(=C1OC)OC)OC(C=C2)(C)C)OC
TCMBANKIN058934	p-hydroxyacetophenone	p-hydroxy-acetophenone; 4'-hydroxyacetophenone; 4-hydroxyacetophenone; Piceol; para-hydroxy-acetophenone; 4′ -Hydroxyacetophenone; c0694; Acetophenone,4'-hydroxy-; C10700; (4-Hydroxyphenyl)ethan-1-one; Ethanone,1-(4-hydroxyphenyl)-; Phenol,p-acetyl-; AB-131/40179700; 99-93-4; p-Hydroxyphenyl methyl ketone; Acetophenone,p-hydroxy-; 4-Hydroksyacetofenol [Polish]; NSC 3698; 1-(4-Hydroxyphenyl)ethanone; AI3-12133; Usaf kf-15; NSC3698; EINECS 202-802-8; p-Oxyacetophenone; WLN: QR DV1; 54180_FLUKA; p-Hydroxyacetophenone; InChI=1/C8H8O2/c1-6(9)7-2-4-8(10)5-3-7/h2-5,10H,1H; 4'-Hydroxyacetophenone; AIDS026793; 1-(4-Hydroxy-phenyl)-ethanone; HYDROXYACETOPHENONE,PARA; 4-Acetylphenol; p-Hydroxacetophenone; ST5213412; Acetophenone,4'-hydroxy- (8CI); 278564_ALDRICH; p-Acetylphenol; AIDS-026793; 4-Hydroxyacetophenone; Methyl-p-hydroxyphenyl ketone; ZINC00330136; Methyl p-hydroxyphenyl ketone; 4-hydroxy-acetophenone	C8H8O2	136.15 g/mol	CC(=O)C1=CC=C(C=C1)O
TCMBANKIN058936	Hypnon	1-Phenylethanone; InChI=1/C8H8O/c1-7(9)8-5-3-2-4-6-8/h2-6H,1H; C07113; Acetylbenzene; ZINC00896628; Ethanone, 1-phenyl-; Acetophenon; 00790_FLUKA; Ketone, methyl phenyl; WLN: 1VR; 442438_SUPELCO; Methyl phenyl ketone; Usaf ek-496; 42163_FLUKA; Ketone, methyl phenyl-; Benzoyl methide; AI3-00575; AIDS-017929; W200905_ALDRICH; FEMA Number 2009; RCRA waste number U004; FEMA No. 2009; Phenyl methyl ketone; NSC 7635; RCRA waste no. U004; NSC7635; A10701_ALDRICH; 98-86-2; CCRIS 1341; AC0; Acetophenone; ST5213401; EINECS 202-708-7; CHEBI:27632; Hypnone; 1-phenylethan-1-one; HSDB 969; Benzoylmethide; 1-Phenyl-1-ethanone; Benzene, acetyl-; c0117; AIDS017929; Acetofenon [Czech]; Acetylbenzol;1-(Phenyl-D5)-Ethanon; NSC 98542-d5; 1-[(2,3,4,5,6-(2)H?)PHENYL]ETHANONE; Acetophenone-(phenyl-d5), 99 atom % D; ACM28077647; DTXSID70466417; Acetophenone-2',3',4',5',6'-d5; Acetophenon-d5; pentadeuterophenyl methyl ketone; FT-0661057; Acetylbenzene-d5; Hypnone-d5; MFCD00064446; 1-(Phenyl-d5)ethanone; 1-(2,3,4,5,6-pentadeuteriophenyl)ethanone; Acetophenone-2/',3/',4/',5/',6/'-d5; SCHEMBL1332185; Methyl (Phenyl-d5) Ketone; DE155; J-016964; 28077-64-7; 1-(Phenyl-d5)-1-ethanone; MolPort-003-929-975; NSC 7635-d5; (Phenyl-d5) Methyl Ketone; Acetophenone-(phenyl-d5); Acetophenone-d5; Acetophenone-2 inverted exclamation marka,3 inverted exclamation marka,4 inverted exclamation marka,5 inverted exclamation marka,6 inverted exclamation marka-d5; Hypnon-d5; 1-Feniletanone-d5; Acetophenone-(phenyl-d5) 99 atom % D; 1-Phenylethanone-d5; Acetophenone-2'3'4'5'6-d5;phenyl-ethanone;acetophenone;phenylethanone;1-phenylethanone	C8H8O	120.15 g/mol	CC(=O)C1=CC=CC=C1
TCMBANKIN058985	rutaevin acetate;Rutaevine acetate	rutaevine acetate		528.6	CC(=O)OC1C(=O)C2C(OC3C2(COC(=O)C3)C4C1(C56C(O5)C(=O)OC(C6(CC4)C)C7=COC=C7)C)(C)C
TCMBANKIN059091	ditertbutyl phthalate	Di-(terc-butilperoxi)ftalato; 30448-43-2; SCHEMBL109178; DTXSID10184527; EINECS 250-204-0; benzene-1,2-dicarboxylic acid ditert-butyl ester; Diperoxyphtalate de tert-butyle; 1,2-Benzenedicarboxylicacid, 1,2-bis(1,1-dimethylethyl) ester; AC1L3T9P; ditertbutyl phthalate; AKOS030616148; CTK4G5219; AK661164; Phthalic acid ditert-butyl ester; Peroxyphthalic acid, di-tert-butyl ester (8CI); Di-(tert-butylperoxy) phthalate, >55% in solution; AC1Q5XKL; ditert-butyl benzene-1,2-dicarboxylate; ZINC5353715; Di-tert-butyl phthalate; ACM30448432; 1,2-DI-TERT-BUTYL PHTHALATE; 134115-67-6	C16H22O4	278.34	CC(C)(C)OC(=O)C1=CC=CC=C1C(=O)OC(C)(C)C
TCMBANKIN059097	1-Hydroxycumene	alpha,alpha-Dimethylbenzyl alcohol; 2-Phenyl-2-propanol; P30802_ALDRICH; alpha,alpha-Dimethylbenzenemethanol; 617-94-7; .alpha.-Cumyl alcohol; EINECS 210-539-5; alpha,alpha-Dimethylbenzene methanol; 2-Propanol, 2-phenyl-; Phenyldimethylcarbinol; NSC1261; Dimethyl phenyl carbinol; 2-PHENYLISOPROPANOL; Benzyl alcohol, .alpha.,.alpha.-dimethyl-; Dimethylphenylmethanol; BRN 1905012; NSC 1261; NSC212537; Benzenemethanol, .alpha.,.alpha.-dimethyl-; NSC 212537; 4-06-00-03219 (Beilstein Handbook Reference); 2-Phenylpropan-2-ol; HSDB 5718; InChI=1/C9H12O/c1-9(2,10)8-6-4-3-5-7-8/h3-7,10H,1-2H; .alpha.,.alpha.-Dimethylbenzyl alcohol; Benzyl alcohol, alpha,alpha-dimethyl-; Benzenemethanol, alpha,alpha-dimethyl-; alpha-Cumyl alcohol; 78940_FLUKA; Dimethylphenylcarbinol; AI3-05532; ZINC01591819;α,α-dimethylbenzene methanol;2-phenyl-2-propanol;alpha-dimethylbenzene methanol	C9H12O	136.19	CC(C)(C1=CC=CC=C1)O
TCMBANKIN059175	delta-elemene	delta-Elemene; g-elemene; cyclohexene,4-ethenyl-4-methyl-3-[1-methylethenyl]-1-[1-methylethyl]-; δ- elemene	C15H24	204.35	CC(C)C1=CC(C(CC1)(C)C=C)C(=C)C
TCMBANKIN059181	1-methylethylbenzene	NaPst;Gedex; Benzene, isopropyl; BENZENE,ISOPROPYL CUMOL; 105270-05-1; 686E; 51609-83-7; Esbrite G 10; Estyrene G-P 4; 61584-90-5; NBS 706; Benzene, (1-methylethyl)-; Estyrene H 61; Dow 860; 11120-46-0; AI3-04630; Afcolene; Copal Z; Krasten 052; Piccolastic A 50; Benzene, (1-methylethyl)-, oxidized, polyphenyl residues; 81834-12-0; Bicolene H; LS 1028E; Carinex GP; MX 4500; Dylite F 40L; 52932-49-7; Bio-Beads S-S 2; 12627-11-1; RCRA waste number U055; Esbrite 2; Estyrene G 15; S 173; (1-Methylethyl)benzene; Propane, 2-phenyl-; Diarex HT 88A; A 3-80; Benzene, ethenyl-, homopolymer; Koplen 2; Bustren; Dow 456; Cosden 550; Dow MX 5514; Carinex tgx/MF; R 3612; NCGC00091155-01; Krasten 1.4; Benzene, (1-methylethyl)-, oxidized, sulfurized by-products; Afcolene 666; 2-Fenilpropano [Italian]; Piccolastic C 125; K 525; HF 77; R 3; 51609-87-1; Dow MX 5516; Esbrite 8; Dylene 9; 475U; Piccolastic A; Diarex HT 88; 68333-89-1; 9055-91-8; Edistir RB; N 4000V; 53112-49-5; Piccolastic; 550P (styrene polymer); Isopropilbenzene [Italian]; 61584-89-2; Afcolene 492; Bustren K 500; Isopropylbenzene; HT-F 76; Piccolastic D-100; Dorvon; BASF III; Isopropylbenzeen; Dorvon FR 100; Dylite F 40; 36698_RIEDEL; Foster grant 834; Dow 1683; HF 55; 54596-41-7; Denka QP3; Piccolastic A 5; 28220_FLUKA; Diarex HT 90; 172641-48-4; HT 88; 2-Fenyl-propaan; 117079-77-3; Piccolastic D; Bicolastic A 75; EINECS 269-798-8; FC-MY 5450; Esbrite LBL; Isopropilbenzene; Lustrex HH 101; Estyrene G 20; Polystyrene resin; Lustrex H 77; C87657_ALDRICH; HHI 11; Pelaspan Esp 109s; Atactic polystyrene; Cumeen [Dutch]; 60328-46-3; C14396; 666U; Diarex HF 55; Latex; Isopropylbenzene [UN1918] [Flammable liquid]; Sulfurized by-product of cumene oxidation; Bustren K 525-19; 55128-06-8; Diarex 43G; Bakelite SMD 3500; Benzene, isopropyl-; Isopropylbenzol; InChI=1/C9H12/c1-8(2)9-6-4-3-5-7-9/h3-8H,1-2H; MX 5517-02; Piccolastic A 25; FG 834; Lustrex HT 88; 68411-37-0; Hostyren N 4000V; Phenol bottoms; Hostyren S; IT 40; CHEBI:34656; Bextrene XL 750; 28230_FLUKA; 98444-30-5; 168N15; BSB-S 40; HSDB 172; Carinex SB 59; Esbrite 500HM; 56451-72-0; Esbrite; Diarex HT 500; 454H; 120037-99-2; Estyrene 500SH; HF 10; Diarex HT 190; MX 5516; NSC8776; NSC 8776; 86090-91-7; ST5214393; Pelaspan 333; Lacqren 506; Ethenylbenzene homopolymer; 2-Fenilpropano; Piccolastic A 75; 68553-94-6; Krasten SB; Bustren Y 825; 98-82-8; Esbrite 4-62; BDH 29-790; BSB-S-E; MX 5514; Esbrite 4; Cadco 0115; 53986-84-8; KR 2537; HH 102; X 600; Cumeen; Carinex SL 273; Hostyren N 4000; 172867-64-0; WLN: 1Y1 & R; Dow 665; Isopropylbenzen; 57657-06-4; KB (Polymer); KM (Polymer); Hostyren N; Esbrite G-P 2; Lustrex; Estyrene 4-62; Benzene, 1-methylethyl-; RCRA waste no. U055; Isopropyl-benzol; 58033-91-3; Carinex HR; 39470-87-6; 2-Fenyl-propaan [Dutch]; BP-Klp; Adion H; Lacqren 550; 2-Phenylpropane; Dylark 250; EINECS 270-120-8; Styrofoam; Diarex YH 476; Bustren U 825; 825TV; Afcolene S 100; HI-Styrol; 144637-93-4; Cosden 945E; Dylene; HT 91-1; Bactolatex; 56748-62-0; Dylene 8G; 31N (styrene polymer); Dylene 8; Propane, 2-phenyl; Ethenylbenzene, homopolymer; Isopropylbenzeen [Dutch]; A 75 (vinyl polymer); Styrene polymer; A 180 (vinyl polymer); 60120-16-3; UN1918; CUMENE; (propan-2-yl)benzene; Bustren Y 3532; Lustrex HP 77; Dow 360; 63849-49-0; Polyphenyl residue; Isopropyl-benzol [German]; Carinex SB 61; Hostyren N 7001; Bustren U 825E11; EINECS 202-704-5; LS 061A; Diarex HF 55-247; Escorez 7404; Cumol; 60880-98-0; 40494-15-3; Diarex HS 77; 9044-64-8; U625; Carinex HRM; Owispol GF; HT 88A; 55465-00-4;cumene	C9H12	120.19 g/mol	CC(C)C1=CC=CC=C1
TCMBANKIN059253	Hexahydro-farnesyl acetone	hexahydro-farnesylacetone; 6,10,14-trimethyl-2-pentadecanone; 6, 10, 14-trimethyl-2-pentadecanone; (6S,10S)-6,10,14-trimethylpentadecan-2-one; 2-pentadecanone,6,10,14-trimethyl-; phytone; 6,10,14-TRIMETHYL-2-PENTADECANONE; hexahydro-farnesyl-acetone; 6,10,14-trimethyl-pentadecan-2-one; C-25231; MFCD00065420; ST049442; 13955-74-3; 2-pentadecanone, 6,10,14-trimethyl; 502-69-2; MCULE-5164481361; AC1Q5H6P; PHYTONE; 6,10,14-Trimethylpentadeca-2-one; 6,10,14-trimethyl pentadecan-2-one; STK761211; OR13502; AN-21434; CTK4J2356; MolPort-001-758-493; (R,R)-Phytone; ZX-AT021772; 2-Pentadecanone,6,10,14-trimethyl-; Hexahydrofarnesyl acetone; 6,10,14-trimethyl-2-pentadecanon; Fitone; AKOS016347358; Hexahydrofarnezylacetone; SBB012620; ZERO/001268; CC-29299; Hexahydrofarnesylacetone; 36116P; 2-Pentadecanone, 6,10,14-trimethyl-; 6,10,14-trimethyl-pentadecane-2-one; W-109084; SCHEMBL716506; Phytol ketone; AKOS001727037; SR-01000526355-1; FT-0632240; SR-01000526355; KB-85744; 6,10,14-Trimethylpentadecan-2-one; hexahydrofarnesylacetone; WHWDWIHXSPCOKZ-UHFFFAOYSA-N; EINECS 207-950-7; AC1L1V4Z; hexahydrofarnesylacetone; 6,10,14-trimethyl-2-pentadecanone; 6,10,14-trimethyl-2-Pentadeeanone; hexahydrofarnesyl acetone; 6,10,14-Trimethylpentadecan-2-one; 2-Pentadecanone, 6,10,14-trimethy-; 6, 10, 14- trimethyl- 2- pentadecanone; (6R,10R)-6,10,14-trimethylpentadecan-2-one; ZINC02169908; 6,10,14-trimethylpentadecan-2-one; 2-pentadecanone,6,10,14-trimethyl; Phytone; hexahydrofarnesyl acetone; perhydrofarnesyl acetone; FITONE	C18H36O	268.5 g/mol	CC(C)CCCC(C)CCCC(C)CCCC(=O)C
TCMBANKIN059259	13-methyl tetradecanoicacid	13-methyl tetradecanoic acid;13-Methylmyristate	C15H30O2	242.4 g/mol	CC(C)CCCCCCCCCCCC(=O)O
TCMBANKIN059260	METHYL ISOPALMITATE	Pentadecanoic acid, 14-methyl-, methyl ester; 14-methylpentadecanoic acid methyl ester; Methyl 14-methylpentadecanoate; 5129-60-2	C17H34O2	270.5 g/mol	CC(C)CCCCCCCCCCCCC(=O)OC
TCMBANKIN059262	diisocapryl phthalate;Diop;diisooctyl phthalate;1,2-benzenedicarboxylic acid,diisooctyl ester	HSDB 588; 1,2-Benzenedicarboxylic acid, diisooctyl ester; bis(6-methylheptyl) benzene-1,2-dicarboxylate; Diisocapryl phthalate; EINECS 248-523-5; Diisooctyl phthalate; 71097-28-4; Phthalic acid, bis(6-methylheptyl)ester; Phthalic acid, diisooctyl ester; AI3-27697-X (USDA); 27554-26-3; Diisooctyl 1,2-benzenedicarboxylate; 1330-91-2; NSC 6381; Di-iso-octyl phthalate; 41375-90-0; benzene-1,2-dicarboxylic acid bis(6-methylheptyl) ester; C14577; DIISOOCTYL PHTHALATE (SEE 27554-26-3); Hexaplas M/O; 25103-50-8; Corflex 880; Flexol Plasticizer DIOP; 1,2-Benzenedicarboxylic acid, 2,2-dimethyl-1,3-propanediyl diisooctyl ester; Isooctyl phthalate	C24H38O4	390.6 g/mol	CC(C)CCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCC(C)C
TCMBANKIN059459	Rutalinidine		C15H17NO4	275.3 g/mol	CC1(C(CC2=C(O1)N(C3=C(C2=O)C=C(C=C3)O)C)O)C
TCMBANKIN059496	evodol		C26H28O9	484.5	CC1(C2=C(C(=O)C3(C(C24COC(=O)CC4O1)CCC5(C36C(O6)C(=O)OC5C7=COC=C7)C)C)O)C
TCMBANKIN059500	glaucin a		C26H30O10		CC1(C2C(=O)C(C3(C(C24COC(=O)CC4O1)CC(C5(C36C(O6)C(=O)OC5C7=COC=C7)C)O)C)O)C
TCMBANKIN059504	12α-hydroxylimonin		C26H30O9		CC1(C2CC(=O)C3(C(C24COC(=O)CC4O1)CC(C5(C36C(O6)C(=O)OC5C7=COC=C7)C)O)C)C
TCMBANKIN059505	evodin		C26H30O8	470.5 g/mol	CC1(C2CC(=O)C3(C(C24COC(=O)CC4O1)CCC5(C36C(O6)C(=O)OC5C7=COC=C7)C)C)C
TCMBANKIN059521	B- pinene;pinene;T-pinene;(-)-nopinene;beta-pinene;bicyclo[3.1.1]heptane,6,6-dimethyl-2-methylene-,(1s);1-β-pinene;()-beta-Pinene;(-)- β- pinene;laevo- β- Pinene		C10H16	136.23 g/mol	CC1(C2CCC(=C)C1C2)C
TCMBANKIN059545	notoginsenoside a		C54H92O24	1125.3 g/mol	CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)O)C)CC(C6C3(CCC6C(C)(CC=CC(C)(C)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C)O)C)C
TCMBANKIN059644	sandaracopimarinol		C20H32O	288.5 g/mol	CC1(CCC2C(=C1)CCC3C2(CCCC3(C)CO)C)C=C
TCMBANKIN059651	NSC 308879		C30H52O3	460.73	CC1(CCCC(O1)(C)C2CCC3(C2C(CC4C3(CCC5C4(CCC(C5(C)C)O)C)C)O)C)C
TCMBANKIN059827	phenol,2,6-bis(1,1-dimethylethyl)-4-methyl		C15H24O	220.35 g/mol	CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C
TCMBANKIN059910	alpha-Cuparenol		C15H22O	218.33	CC1=CC=C(C=C1)C2(CCC(C2(C)C)O)C
TCMBANKIN059911	cuparene		C15H22	202.33 g/mol	CC1=CC=C(C=C1)C2(CCCC2(C)C)C
TCMBANKIN059942	Tectochinon		C15H10O2	222.24 g/mol	CC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3C2=O
TCMBANKIN059950	Cadalin		C15H18	198.3	CC1=CC2=C(C=CC(=C2C=C1)C)C(C)C
TCMBANKIN059962	cadinen;α-Cadinene;1,2,4a,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)naphthalene;1,2,4A,5,6,8A-hexahydro--4,7-dimethyl-(1-methylethyl)-naphthalene;muurolene;1,2,4a,5,6,8a- hexhydro- 4,7- dimethyl- 1-(1- methylethyl)-(1alpha 4a． alpha．,8a alpha． )- naphthalene;alpha cadinene;α-muurolene		C15H24	204.35 g/mol	CC1=CC2C(CC1)C(=CCC2C(C)C)C
TCMBANKIN059966	huperzine b		C16H20N2O	256.34 g/mol	CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2CCCN4
TCMBANKIN059982	d-limonene		C10H16	136.23 g/mol	CC1=CCC(CC1)C(=C)C
TCMBANKIN060009	copaene; (-)-Alpha-Copaene; α-copaene		C15H24	204.35 g/mol	CC1=CCC2C3C1C2(CCC3C(C)C)C
TCMBANKIN060014	Germacrene D		C15H24	204.35 g/mol	CC1=CCCC(=C)C=CC(CC1)C(C)C
TCMBANKIN060183	ginsenoside- Re		C48H82O18	947.15	CC1C(C(C(C(O1)OC2C(C(C(OC2OC3CC4(C(CC(C5C4(CCC5C(C)(CCC=C(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)O)C7(C3C(C(CC7)O)(C)C)C)C)CO)O)O)O)O)O
TCMBANKIN060264	rutin		C27H30O16	610.5 g/mol	CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O
TCMBANKIN060561	delta-guaiene		C15H24	204.35 g/mol	CC1CCC2=C(CCC(CC12)C(=C)C)C
TCMBANKIN060571	(-)-trifara-9,14-diene		C15H24	204.35 g/mol	CC1CCC2C(=C)C1(CCC2(C)C=C)C
TCMBANKIN060575	alpha-gurjunene		C15H24	204.35 g/mol	CC1CCC2C(C2(C)C)C3=C(CCC13)C
TCMBANKIN060652	cyclo-(ile-val); 3-isopropyl-6-isobutyl-2,5-dioxopiperazine		C11H20N2O2	212.29 g/mol	CCC(C)C1C(=O)NC(C(=O)N1)C(C)C
TCMBANKIN060679	stigmasterol		C29H48O	412.7 g/mol	CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C
TCMBANKIN060680	stigmasterol-3-glucoside		C35H58O6	574.83 g/mol	CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C
TCMBANKIN060691	poriferast-5-en-3beta-ol;22,23-dihydrostigmasterol;gamma-sitosterol;clionasterol;beta-dihydrofucosterol		C29H50O	414.71 g/mol	CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C
TCMBANKIN060693	Sitogluside		C35H60O6	576.85g/mol	CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C
TCMBANKIN060698	2-methyl-2pentenal		C6H10O	98.14 g/mol	CCC=C(C)C=O
TCMBANKIN060708	9,12,15-Octadecatrien-1-ol,(Z,Z,Z)		C18H32O	264.45 g/mol	CCC=CCC=CCC=CCCCCCCCCO
TCMBANKIN060774	(-)2d,4d,6d,8d-tetramethyl undecanoic acid		C15H30O2	242.4 g/mol	CCCC(C)CC(C)CC(C)CC(C)C(=O)O
TCMBANKIN060790	leaf aldehyde		C6H10O	98.14 g/mol	CCCC=CC=O
TCMBANKIN060820	1-methyl-2-[(z)-6-undecenyl]-4(1h)-quinolone		C21H29NO	311.5 g/mol	CCCCC=CCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN060827	Valeraldehyde		C5H10O	86.13g/mol	CCCCC=O
TCMBANKIN060873	arachidonic acid		C20H32O2	304.5 g/mol	CCCCCC=CCC=CCC=CCC=CCCCC(=O)O
TCMBANKIN060876	5,8-tetradecadienoic acid		C14H24O2	224.34g/mol	CCCCCC=CCC=CCCCC(=O)O
TCMBANKIN060877	1-methyl-2-[(4z,7z)-4,7-tridecadienyl]-4(1h)-quinolone		C23H31NO	337.5 g/mol	CCCCCC=CCC=CCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN060878	1-methyl-2-[(6z,9z)-6,9-pentadeca-dienyl]-4(1h)-quinolone		C25H35NO	365.6 g/mol	CCCCCC=CCC=CCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN060881	linoleic acid ethyl ester		C20H36O2	308.5 g/mol	CCCCCC=CCC=CCCCCCCCC(=O)OCC
TCMBANKIN060886	1-methyl-2-[(z)-7-tridecenyl]-4(1h)-quinolone		C23H33NO	339.5 g/mol	CCCCCC=CCCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN060888	caproaldehyde		C6H12O	100.16 g/mol	CCCCCC=O
TCMBANKIN060897	enanthic acid		C7H13O2-	129.18 g/mol	CCCCCCC(=O)[O-]
TCMBANKIN060910	cis-9-hexadecenoic acid		C16H30O2	254.41 g/mol	CCCCCCC=CCCCCCCCC(=O)O
TCMBANKIN060918	WLN: VH6		C7H14O	114.19	CCCCCCC=O
TCMBANKIN060935	panaxynol		C17H24O	244.37	CCCCCCCC=CCC#CC#CC(C=C)O
TCMBANKIN060944	nonanoic acid		C9H18O2	158.24 g/mol	CCCCCCCCC(=O)O
TCMBANKIN060958	oleic acid;cis-oleic acid;oleinic acid		C18H34O2	282.46	CCCCCCCCC=CCCCCCCCC(=O)O
TCMBANKIN060995	1-methyl-2-nonacosyl-4-quinolone		C19H27NO	285.4 g/mol	CCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN061006	lauric acid		C12H24O2	200.32	CCCCCCCCCCCC(=O)O
TCMBANKIN061011	1-tridecene; Tridecylene; tridecene		C13H26	182.35	CCCCCCCCCCCC=C
TCMBANKIN061015	1-methyl-2-undecyl-4-quinolone		C21H31NO	313.5 g/mol	CCCCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN061024	tetradecane		C14H28	196.39 g/mol	CCCCCCCCCCCCC=C
TCMBANKIN061029	myristic acid		C14H28O2	228.37	CCCCCCCCCCCCCC(=O)O
TCMBANKIN061036	methyl pentadecanoate		C16H32O2	256.42	CCCCCCCCCCCCCC(C)C(=O)O
TCMBANKIN061042	2-tridecyl-1-methyl-4(1h)-quinolone				CCCCCCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN061043	MYS		C15H32	212.41	CCCCCCCCCCCCCCC
TCMBANKIN061044	Pentadecanoate		C15H29O2-	241.39 g/mol	CCCCCCCCCCCCCCC(=O)[O-]
TCMBANKIN061058	n-hexadecane		C16H34	226.44 g/mol	CCCCCCCCCCCCCCCC
TCMBANKIN061071	Ethylpalmitate		C18H36O2	284.5 g/mol	CCCCCCCCCCCCCCCC(=O)OCC
TCMBANKIN061084	1-methyl-2-pentadecyl-4-quinolone		C25H39NO	369.6 g/mol	CCCCCCCCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1C
TCMBANKIN061085	n-heptadecane;heptadecane;Heptadekan		C17H36	240.5 g/mol	CCCCCCCCCCCCCCCCC
TCMBANKIN061090	n-octadecane;Oktadekan;octadecane		C18H38	254.49g/mol	CCCCCCCCCCCCCCCCCC
TCMBANKIN061091	stearic acid		CH3(CH2)16COOH	284.5 g/mol	CCCCCCCCCCCCCCCCCC(=O)O
TCMBANKIN061100	nonadecane		C19H40	268.5 g/mol	CCCCCCCCCCCCCCCCCCC
TCMBANKIN061101	Nonadecylic acid		C19H38O2	298.5 g/mol	CCCCCCCCCCCCCCCCCCC(=O)O
TCMBANKIN061102	LFA		C20H42	282.55 g/mol	CCCCCCCCCCCCCCCCCCCC
TCMBANKIN061111	heneicosane		C21H44	296.57	CCCCCCCCCCCCCCCCCCCCC
TCMBANKIN061112	heneicosanoicacid		C21H42O2	326.6 g/mol	CCCCCCCCCCCCCCCCCCCCC(=O)O
TCMBANKIN061116	n-docosane;TWT;docosane		C22H46	310.6 g/mol	CCCCCCCCCCCCCCCCCCCCCC
TCMBANKIN061141	n-hentriacontane		C31H64	436.8 g/mol	CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
TCMBANKIN061170	heptadecanol		C17H36O	256.47	CCCCCCCCCCCCCCCCCO
TCMBANKIN061174	Tetradecanol		C14H30O	214.39 g/mol	CCCCCCCCCCCCCCO
TCMBANKIN061212	n-butyl pyroglutamate		C9H15NO3		CCCCOC(=O)C1CCC(=O)N1
TCMBANKIN061261	ethyl pyroglutamate		C7H11NO3	157.17 g/mol	CCOC(=O)C1CCC(=O)N1
TCMBANKIN061290	MeODMT;n,n-dimethyl-5-methoxy tryptamine		C13H18N2O	218.29	CN(C)CCC1=CNC2=C1C=C(C=C2)OC
TCMBANKIN061298	GoshuyuamideII		C19H17N3O2	319.39	CN1C2=CC=CC=C2C(=O)N(C1=O)CCC3=CNC4=CC=CC=C43
TCMBANKIN061377	Goshuyuamide I	AC1NSW2R; (2-methylaminophenyl)-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)methanone; [2-(methylamino)phenyl]-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)methanone; (2-methylaminophenyl)-(1,3,4,9-tetrahydro-$b-carbolin-2-yl)methanone; goshuyuamide i	C19H19N3O	305.41	CNC1=CC=CC=C1C(=O)N2CCC3=C(C2)NC4=CC=CC=C34
TCMBANKIN061378	n-(2-methulaminobenzoyl)tryfamine	N-(2-Methylaminobenzoyl)tryptamine; N-[2-(1H-indol-3-yl)ethyl]-2-methylamino-benzamide; N-[2-(1H-indol-3-yl)ethyl]-2-methylaminobenzamide; n-(2-methylaminobenzoyl)tryptamine; N-[2-(1H-indol-3-yl)ethyl]-2-(methylamino)benzamide; AC1NSY7J		293.4	CNC1=CC=CC=C1C(=O)NCCC2=CNC3=CC=CC=C32
TCMBANKIN061384	synephrine	M-2845;oxedrine	C9H13NO2	167.2 g/mol	CNCC(C1=CC=C(C=C1)O)O
TCMBANKIN061474	3, 4-dimethoxybenzaldehyde	DSSTox_CID_6285; Verapamil Impurity G; 4,3-dimethoxybenzaldehyde; D0507; RTC-010113; BBL010373; SBB040236; AH-034/32845024; F2190-0618; Benzaldehyde, 3,4-dimethoxy-; 3,4-dimethoxybenzaldehyde (veratraldehyde); FT-0600118; FEMA 3109; AC1Q4FDU; LS-628; BC622797; Veratrumaldehyde; 107052-EP2374783A1; BR-46721; 3,4-DIMETHOXYBENZALDEHHYDE; ACN-051072; NCGC00091642-02; Vanillin methyl ether; 3,4-Dimethoxybenzenecarbonal; AM20050100; Protocatechuecaldehyde dimethyl ether; ST45169641; 3,4-Dimethoxybenzaldehyde, 99%; VERATRALDEHYDE; p-Veratric aldehyde; AB1000043; TIMTEC-BB SBB040236; DSSTox_GSID_26285; Protocatechuic aldehyde dimethyl ether; CCRIS 6285; ACT06905; LABOTEST-BB LT00235863; I01-2283; Protocatechualdehyde dimethyl ether; OTAVA-BB 1180632; VERATRYLALDEHYDE; CTK0H5284; PubChem8238; KB-28345; InChI=1/C9H10O3/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-6H,1-2H; 107052-EP2295423A1; ANW-17460; ZB006061; NSC-8500; AC1Q46T0; WLN: VHR CO1 DO1; DTXSID7026285; AS-11996; Veratrum aldehyde; 3,4-Dimethoxy benzaldehyde; CHEMBL1088937; MFCD00003363; Tox21_201566; STK188425; 4CN-0811; TL806334; DSSTox_RID_78087; 3,4-dimethoxybenzaldeyde; NCGC00257217-01; Benzaldehyde, 3,4-dimethoxy-veratraldehyde; 3,4-Dimethoxybenzaldehyde (Verapamil Related Compound E - USP), Pharmaceutical Secondary Standard; Certified Reference Material; KSC175E8J; BB_NC-2052; Vanillin methyl ether; Veratraldehyde; AC1L1QYK; NSC 24521; 3,4dimethoxybenzaldehyde; NSC24521; NCGC00259115-01; AKOS000118989; Benzaldehyde,4-dimethoxy-; 4-O-Methylvanillin; AI3-08099; Veratric aldehyde; 3,4-dimethoxybenzaidehyde; 107052-EP2377841A1; CM13990; RP22905; UI88P68JZD; AKOS BBS-00003208; SCHEMBL25202; TC-010113; bmse010220; LABOTEST-BB LT03331050; MolPort-000-871-214; WJUFSDZVCOTFON-UHFFFAOYSA-N; Methylvanillin; AS02987; NSC8500; ST2410267; UNII-UI88P68JZD; BRN 0473899; 107052-EP2298744A2; AN-22815; KS-00000AZ9; MCULE-1202068347; 120-14-9; NE10275; NSC-24521; TRA0003531; 4,5-dimethoxybenzaldehyde; AC-10201; 3,4-DIMETHOXY-BENZALDEHYDE; C02201; CAS-120-14-9; DB-014213; 3,4-Dimethoxybenzaldehyde; CHEBI:17098; NCGC00091642-01; 3, 4-Dimethoxybenzaldehyde; AJ-13584; 3,4 dimethoxybenzaldehyde; FEMA No. 3109; Veratral; CJ-01437; Veratraldehyde, >=98%, FG; ACMC-209a6e; NCGC00091642-03; AK-46721; Tox21_303074; W-108485; ZINC155456; CS-W019906; SC-00570; Verapamil Related Compound E, United States Pharmacopeia (USP) Reference Standard; EINECS 204-373-2; Veratryl aldehyde; ST5213394; AH-034/32845024; InChI=1/C9H10O3/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-6H,1-2H; 3,4-Dimethoxybenzaldehyde; Benzaldehyde, 3,4-dimethoxy-; 94860_FLUKA; CHEBI:17098; WLN: VHR CO1 DO1; C02201; NCGC00091642-01; Veratrum aldehyde; NCGC00091642-02; Vanillin methyl ether; Methylvanillin; FEMA No. 3109; 3,4-Dimethoxybenzenecarbonal; Protocatechuecaldehyde dimethyl ether; W310905_ALDRICH; NSC8500; ZINC00155456; p-Veratric aldehyde; BRN 0473899; Veratraldehyde; Protocatechuic aldehyde dimethyl ether; CCRIS 6285; 120-14-9; NSC24521; NSC 24521; 4-O-Methylvanillin; 4-08-00-01765 (Beilstein Handbook Reference); AI3-08099; 143758_ALDRICH; Protocatechualdehyde dimethyl ether; Veratric aldehyde; EINECS 204-373-2; 3,4-DIMETHOXY-BENZALDEHYDE; Veratryl aldehyde; veratraldehyde; methylvanillin; Veratral	C9H10O3	166.17 g/mol	COC1=C(C=C(C=C1)C=O)OC
TCMBANKIN061786	elemicine	el-emicine，Elemicine; elemicin ; Elemicin; Benzene, 5-(2-propenyl)-1,2,3-trimethoxy; AX8052814; CJ-04512; C10451; V6154; KS-00000EX2; TC-307841; 4-allyl-1,2,6-trimethoxybenzene; CHEBI:4771; KB-85683; 5-Allyl-1,2,3-trimethoxybenzene; 1,2,3-Trimethoxy-5-allylbenzene; NSC16704; K-9190; BRN 1912664; TRA0018883; 5-(Prop-2-en-1-yl)-1,2,3-trimethoxybenzene; 1,2,3-Trimethoxy-5-allylbenzene (elemicin); SCHEMBL68542; EINECS 207-649-0; CTK4J0963; 5'-metoxy eugenol; ZB015169; ST24044297; AKOS015896443; CCRIS 6783; Benzene, 1,2,3-trimethoxy-5-(2-propenyl)-; 10005-761a; 1,2,3-Trimethoxy-5-(2-propenyl)-benzene; 1,2,3-trimethoxy-5-(prop-2-en-1-yl)benzene; Benzene,1,2,3-trimethoxy-5-(2-propen-1-yl)-; A827594; 1,2,3-Trimethoxy-5-[2-propenyl]-benzene; I06-1928; 1,2,3-Trimethoxy-5-(2-propenyl)benzene; DTXSID60197586; ZINC899845; 3,4,5-Trimethoxyallylbenzene; MFCD01656688; BPLQKQKXWHCZSS-UHFFFAOYSA-N; AI3-20815; AN-843; CHEMBL458690; 487A116; OR40002; 487-11-6; 5-allyl-1,2,3-trimethoxybenzene; AK116942; ZX-AT003475; Benzene, 1,2,3-trimethoxy-5-(2-propenyl)- (9CI); J-520432; NSC-16704; MolPort-003-824-417; 3,4, 5-Trimethoxyallylbenzene; RP26424; LS-29056; 5-allyl-1,2,3-trimethoxy-benzene; HSZ191AKAN; AC1L1USQ; 4-allyl-1,2,6-trimethoxy benzene; 1,2,3-Trimethoxy-5-(2-propenyl)benzene, 9CI; NSC 16704; AJ-24292; Benzene,2,3-trimethoxy-5-(2-propenyl)-; SY018605; 1,2,3-trimethoxy-5-prop-2-enyl-benzene; 1,2,3-trimethoxy-5-prop-2-enylbenzene; FT-0652063; ST51053296; Benzene, 5-allyl-1,2,3-trimethoxy-; BENZENE, 5-ALLYL-1,2,3-TRIMETHOXY-; DB-081347; 3,5-Trimethoxyallylbenzene; PS-4970; UNII-HSZ191AKAN; 3-(3,4,5-Trimethoxyphenyl)-1-propene; 4-06-00-07478 (Beilstein Handbook Reference)	C12H16O3	208.25 g/mol	COC1=CC(=CC(=C1OC)OC)CC=C
TCMBANKIN061915	3-dimethylallyl-4-methoxy-2-quinolone	3,3-dimethylallyl-4-methoxy-2-quinolone;2-(nonan-8-one)-(1h)-4-quinolone	C18H23NO2		COC1C2=CC=CC=C2NC(=O)C1(CCC=C)CCC=C
TCMBANKIN015100	flavonoid glycoside
TCMBANKIN015269	ginsenoside rbl		C54H92O23	1109.3 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C
TCMBANKIN036872	ginsenoside Rh2	ginsenoside-rh2; 78214-33-2; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(1S)-1-hydroxy-1,5-dimethylhex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-tri; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-methylol-tetrahydropyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(1S)-1-hydroxy-1,5-dimethyl-hex-4-enyl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-tr; beta-D-Glucopyranoside, (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl; ginsenoside rh 2; Ginsenoside Rg3 metabolite; ginsenoside rh-2	C36H62O8	623	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])( [H])C2([H])[H])[C@@]23C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@@]5([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])( O[H])[C@@]5([H])O[H]
TCMBANKIN040444	ginsenoside rc	2-[[2-[[17-[2-[[6-[[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]oxymethyl]-3,4,5-trihydroxy-2-oxanyl]oxy]-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,10,14-tetramethyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydr; ginsenosiderc; I06-0733; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-[[5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,10,14-tetramethyl-12-oxidanyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocy; A802167	C53H90O22	1079.27	CC(=CCCC(C)(C1CCC2(C1C(CC3C2CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C
TCMBANKIN058867	ginsenoside rb1	Q-100470; A-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl ; GRb 1; MFCD00133367; ginsenosiderb1; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root, triterpenoid saponin; beta-D-Glucopyranoside, (3-beta,12-beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-; N1620; NSC 310103; CHEBI:67989; Ginsenoside Rb1, primary pharmaceutical reference standard; C20713; Panax saponin E; 7413S0WMH6; Pseudoginsenoside D; 87700-07-0; A-Glucopyranosyl-(3; C54H92O23; A)-20-[(6-O-; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl-beta-D-glucopyranoside; Ginsenoside Rb1, European Pharmacopoeia (EP) Reference Standard; (3beta,12beta)-20-{[6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; 20(S)-ginsenoside Rb1; 2-O-; Ginsenoside Rb1 (saponin of panax ginseng); 52286-61-0; 12770-17-1; 393829-67-9; CS-3829; BIDD:ER0108; A,12; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl beta-D-glucopyranoside; GZYPWOGIYAIIPV-JBDTYSNRSA-N; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root; GS-Rb1; 41753-43-9; ginsenoside-rb1; ginsenoside r b1; 212055-66-8; UNII-7413S0WMH6; AB0016710; AKOS025311537; A-D-glucopyranoside; Ginsenoside rb1; MolPort-016-638-397; gensenoside Rb1; Gypenoside III; ginsenoside Rb1; CHEMBL501515; HY-N0039; Gynosaponin C; BDBM50317541; (3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; Ambap41753-43-9; GSRb1; Ginsenoside-Rb1; 753G439; Sanchinoside E1; A-D-glucopyranosyl-; Panaxsaponin E; O899; ginsenoside-Rb1;gypenosideIII	C54H92O23	1109.3 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C
TCMBANKIN031470	gypenosideix	Gypenoside IX; gypenoside ix	C47H80O17	917.13	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(CO7)O)O)O)O)O)O)C
TCMBANKIN036873	Ginsenoside Rd	ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6		947
TCMBANKIN037051	notoginsenoside D		C64H108O31	1374	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](C([H])([H])[H])(C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])O[C@@]2([H]) O[C@]([H])(C([H])([H])O[C@@]3([H])O[C@]([H])(C([H])([H])O[C@@]4([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])[C@@]([H])(O[H])[C@]([H])( O[H])[C@@]2([H])O[H])C([H])([H])C5([H])[H])[C@@]56C([H])([H])[H])[C@@]6(C([H])([H])[H])C([H])([H])C7([H])[H])[C@@]7([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@@]8([H])O[C@]([H])(C([H])([H])O[ H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]8([H])O[C@@]9([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]9([H])O[C@@]%10([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]%10([H])O[H]
TCMBANKIN038189	gypenoside XVII	Gypenoside XVII; gypenosidexvii; gypenosideXVII	C48H82O18	947	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@](O[C@]([H])(O[C@]([H])(C([H])([H])O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]2([H])O[H])[C@]( [H])(O[H])[C@@]2([H])O[H])[C@@]3([H])O[H])[C@]([H])(O[H])[C@@]3([H])O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]45C([H])([H])[H])[C@ @]5(C([H])([H])[H])C([H])([H])C6([H])[H])[C@@]6([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]7([H])O[H])[C@]([H])(O[H])[C@@]7([H])O[H]
TCMBANKIN038912	Notoginsenoside S			1359
TCMBANKIN040444	ginsenoside rc	2-[[2-[[17-[2-[[6-[[3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]oxymethyl]-3,4,5-trihydroxy-2-oxanyl]oxy]-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,10,14-tetramethyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydr; ginsenosiderc; I06-0733; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-[[5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,10,14-tetramethyl-12-oxidanyl-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocy; A802167	C53H90O22	1079.27	CC(=CCCC(C)(C1CCC2(C1C(CC3C2CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C
TCMBANKIN042472	Notoginsenoside O			1049.2 g/mol
TCMBANKIN045376	notoginsenoside t		C64H108O31	1373.5 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(CO7)O)O)O)C)C)O)C)OC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)OC1C(C(C(CO1)O)O)O)O)O)O)O)C
TCMBANKIN047535	notoginsenoside p		C52H88O21	1049.2 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)OC6C(C(C(C(O6)COC7C(C(C(CO7)OC8C(C(C(CO8)O)O)O)O)O)O)O)O)C
TCMBANKIN049826	notoginsenoside Q		C63H106O30	1343	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])[C@@]([H])(O[H])[C@]([H])([C@@]([H])([C@@](O[C@]2([H])O[C@]([H])(C([H])([H])O[C@]3([H])OC([H])([H])[C@@]([H])(O[C@]4([H])OC([H])([H])[ C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])[C@]([H])(O[H])[C@@]3([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H]) [H])C([H])([H])C5([H])[H])[C@@]56C([H])([H])[H])[C@@]6(C([H])([H])[H])C([H])([H])C7([H])[H])[C@@]7([H])C(C([H])([H])[H])(C([H])([H])[H])[C@]1([H])O[C@]8([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H]) [C@]([H])(O[H])[C@@]8([H])O[C@]9([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]9([H])O[C@]%10([H])OC([H])([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]%10([H])O[H]
TCMBANKIN058861	ginsenoside rd;20-glucosylginsenosiderf;20-glucosylginsenosiderf	ginsenoside-rd; ginsenosiderd; A829210; 2-(hydroxymethyl)-6-[6-(hydroxymethyl)-2-[[17-[2-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-methyl-hept-5-en-2-yl]-4,4,8,10,14-pentamethyl-3,12-bis(oxidanyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-b; 2-[[2-[[3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]hept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)-3-oxanyl]oxy]-6;(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(6S,14R)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; 20-glucosylginsenoside rf; AC1O3DDF;;20-glucosylginsenosiderf;20-glucosylginsenosiderf	C48H82O18	947.15	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)O)C)OC7C(C(C(C(O7)CO)O)O)O)C
TCMBANKIN058867	ginsenoside rb1	Q-100470; A-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl ; GRb 1; MFCD00133367; ginsenosiderb1; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root, triterpenoid saponin; beta-D-Glucopyranoside, (3-beta,12-beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-; N1620; NSC 310103; CHEBI:67989; Ginsenoside Rb1, primary pharmaceutical reference standard; C20713; Panax saponin E; 7413S0WMH6; Pseudoginsenoside D; 87700-07-0; A-Glucopyranosyl-(3; C54H92O23; A)-20-[(6-O-; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-((6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl-beta-D-glucopyranoside; Ginsenoside Rb1, European Pharmacopoeia (EP) Reference Standard; (3beta,12beta)-20-{[6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; 20(S)-ginsenoside Rb1; 2-O-; Ginsenoside Rb1 (saponin of panax ginseng); 52286-61-0; 12770-17-1; 393829-67-9; CS-3829; BIDD:ER0108; A,12; 2-O-beta-Glucopyranosyl-(3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl beta-D-glucopyranoside; GZYPWOGIYAIIPV-JBDTYSNRSA-N; Ginsenoside-Rb1 from Panax ginseng (Korean ginseng) root; GS-Rb1; 41753-43-9; ginsenoside-rb1; ginsenoside r b1; 212055-66-8; UNII-7413S0WMH6; AB0016710; AKOS025311537; A-D-glucopyranoside; Ginsenoside rb1; MolPort-016-638-397; gensenoside Rb1; Gypenoside III; ginsenoside Rb1; CHEMBL501515; HY-N0039; Gynosaponin C; BDBM50317541; (3beta,12beta)-20-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside; Ambap41753-43-9; GSRb1; Ginsenoside-Rb1; 753G439; Sanchinoside E1; A-D-glucopyranosyl-; Panaxsaponin E; O899; ginsenoside-Rb1;gypenosideIII	C54H92O23	1109.3 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C
TCMBANKIN058869	ginsenoside Rb3	ginsenoside rb3; ginsenoside r b3; gensenoside- Rb3; ginsenoside- Rb3; gensenoside Rb3; ginsenosiderb3; ginsenoside-rb3	C53H90O22	1079.3 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(CO8)O)O)O)O)O)O)C
TCMBANKIN058873	Notoginsenoside Fc	notoginsenoside fc; Notoginsenoside Fa; notoginsenoside fa	C59H100O27	1241.4 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(CO7)O)O)O)C)C)O)C)OC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)O)O)O)O)O)C
TCMBANKIN060680	stigmasterol-3-glucoside		C35H58O6	574.83 g/mol	CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C
TCMBANKIN060685	7-stigmastenol-3-o-β-d-glucoside		C35H60O6	576.85	CCC(CCC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C
TCMBANKIN060935	panaxynol		C17H24O	244.37	CCCCCCCC=CCC#CC#CC(C=C)O
TCMBANKIN015100	flavonoid glycoside

植物对应的疾病

疾病ID	病名	疾病类型	MeSH	参考文献

植物对应的靶点

靶点ID	基因名	基因别名	描述	染色体位置	Map_Location	基因类型

TCMBank_ID:

TCMBANKHE004506
TCMBANKHE004505
TCMBANKHE006552
TCMBANKHE000220

YEM_ID:

YEM-137

ID:

TCMBANKHE004506/YEM-137
TCMBANKHE004505/YEM-137
TCMBANKHE006552/YEM-137
TCMBANKHE000220/YEM-137

植物拉丁名:

Radix Notoginseng|Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al.

Panax pseudo-ginseng var. notoginseng [Syn. Panax notoginseng ]|Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al.

Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al.

功能与主治:

药用植物名:

三七
汉三七|三七
三七花蕾|三七
三七叶|三七

药名:

三七

来源:

云南民族药物志：第一卷

药用部位:

root
Panax notoginseng (Burk. ) F. H. Chen.
flower

使用民族:

彝族

药味:

Warm; Pungent; Slightly Bitter

经络:

Stomach; Liver

临床特征:

1. Flavonoid glycoside, one of its components, increases coronary flow, reduces myocardial oxygen consumption and lowers arterial pressure.2.Cardiotonic on frogs' hearts in vitro; low concentration of its extract exerts a vasoconstrictive effect on the ve

治疗类型:

化瘀止血药
止血

TCM_ID_id:

2443
1452
8120
3617

SymMap_id:

346

TCMSP_id:

602
317

TCMBank_ID:

TCMBANKHE004506TCMBANKHE004505TCMBANKHE006552TCMBANKHE000220

YEM_ID:

YEM-137

ID:

TCMBANKHE004506/YEM-137TCMBANKHE004505/YEM-137TCMBANKHE006552/YEM-137TCMBANKHE000220/YEM-137

植物拉丁名:

Radix Notoginseng|Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al. Panax pseudo-ginseng var. notoginseng [Syn. Panax notoginseng ]|Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al. Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al.

功能与主治:

药用植物名:

三七汉三七|三七三七花蕾|三七三七叶|三七

药名:

三七

来源:

云南民族药物志：第一卷

药用部位:

rootPanax notoginseng (Burk. ) F. H. Chen.flower

使用民族:

彝族

药味:

Warm; Pungent; Slightly Bitter

经络:

Stomach; Liver

临床特征:

1. Flavonoid glycoside, one of its components, increases coronary flow, reduces myocardial oxygen consumption and lowers arterial pressure.2.Cardiotonic on frogs' hearts in vitro; low concentration of its extract exerts a vasoconstrictive effect on the ve

治疗类型:

化瘀止血药止血

TCM_ID_id:

2443145281203617

SymMap_id:

346

TCMSP_id:

602317

TCMBANKHE004506
TCMBANKHE004505
TCMBANKHE006552
TCMBANKHE000220

TCMBANKHE004506/YEM-137
TCMBANKHE004505/YEM-137
TCMBANKHE006552/YEM-137
TCMBANKHE000220/YEM-137

Radix Notoginseng|Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al.

Panax pseudo-ginseng var. notoginseng [Syn. Panax notoginseng ]|Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al.

Panax notoginseng (Burk.) F, H. Chen ex C.Chow et al.

三七
汉三七|三七
三七花蕾|三七
三七叶|三七

root
Panax notoginseng (Burk. ) F. H. Chen.
flower

化瘀止血药
止血

2443
1452
8120
3617

602
317